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ABSTRACT
Herpetic stromal keratitis (HSK) is an immunopathological and tissue destructive
corneal lesion caused by herpes simplex virus (HSV) infection, which induces an
intense inflammatory response and finally leads to blindness. Accumulating
evidence using the murine model has shown that Th-1 phenotype CD4+ T cells
orchestrating the inflammation mainly contribute to the immunopathological
reaction in HSV-1 infected cornea. However, prior to CD4+ T cell infiltration into
corneal lesions, various innate immune cells recruit and produce numerous
inflammatory and angiogenic molecules into the corneal stroma those in turn drive
the corneal immunopathology.
The first part (Part I) of this dissertation focuses on the understanding of
HSV-1 induced immunoinflammatory processes in the cornea and trigeminal
ganglia including the secondary lymphoid tissues. The next three parts (Part II-IV)
focus on different inflammatory and anti-inflammatory mechanisms that are
activated following virus infection in the cornea. Results in Part II evaluate the role
of various Toll-like receptors (TLRs) in driving the early inflammatory events that
occur in the HSV infected corneas. Thus, this part demonstrates that mainly TLR2
and to a lesser extent TLR9 ligand activity of HSV is important for driving SK
pathology. Results of the third section show that HSV infection results in the up
regulation of IL-23 that is needed for the survival of pathogenic Th-17 cells. The
data show that mice lacking IL-23 were more susceptible to SK lesions and that the
heightened lesion severity was attributed to higher IL-12 production and Th1
immune response in such animals. The fourth section describes the relative role of
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IL-10 and natural regulatory T cells (nTregs) as two independent anti-inflammatory
mechanisms that are needed for controlling HSK lesions.
In this study, experiments were designed to understand the mechanisms
involved in the induction and regulation of immunopathology in HSK and
modulation of such processes could be useful in designing therapeutic for HSK.
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Part-I
Background and overview
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CLINICAL BACKGROUND
Herpes simplex virus (HSV) induced eye diseases are one of the commonest
causes of unilateral infectious blindness in the western world [1]. Epidemiological
studies in the United states reveal that, 400,000 persons are affected, with 20,000
new cases occurring annually with the incidence ranging from 4.1- 20.7 cases/100
000 patients per year [2]. Results from surveys conduced by the National Health
and Nutrition Examination between 1976 and 1980 (NHANES II) and again
between 1988 and 1994 (NHANES III) showed a 30% increase in HSV-2 specific
antibodies within the studied timeframe in the United States [3]. In contrast the age
specific seroprevalence of HSV-1 has decreased in the industrial countries with an
exception to several developing countries [3]. Ocular lesions are mostly caused by
HSV type 1 and very rarely by HSV type 2 infections. However, 80% of neonatal
herpes infection is caused by HSV-2 although both strains can be involved.
Classically, the life cycle of HSV in the host is divided into four stages
namely, entry, spread, establishment of latency and reactivation. After the primary
infection of the skin or mucosal surfaces with HSV, it spreads to the neuronal cell
bodies where latency is established [1]. It is currently believed that the virus
reactivation is kept in check by host immune cells in the sensory ganglion [4]. The
psychological and physical stresses that result in temporary impairment of the
immune system facilitate the reactivation of HSV and subsequent release of the
virus to the periphery [5]. Most ocular HSV infections result in acute epithelial
keratitis that can be controlled with several antiviral drugs [6]. Twenty percent of
the patients infected ocularly with HSV develop, a chronic vision impairing
stromal lesion known as herpetic stromal keratitis (HSK). In humans,
2

approximately 50% of HSK occurs as a consequence of virus reactivation from the
trigeminal ganglion and only ~2% of such cases result directly from primary HSV
infection [1]. The chances of developing SK are three times greater following a
recurring herpetic keratitis than following a primary infection [1].
Symptoms of HSK lesions includes, corneal necrosis and ulceration,
stromal edema and neovascularization [7]. These lesions are shown to occur
mainly as a result of T cell mediated immunopathological responses in the cornea
whose pathogenesis are poorly understood. Forty to ninety percent of the patients
with stromal keratitis may develop disciform keratitis (corneal endothelium is the
main site of damage), while the rest of the patients may develop stromal opacities
[1]. If not treated properly, it may lead to corneal scarring and ulcerations
warranting corneal transplantation. Apart from stromal keratitis, HSV infection
could also result in viral retinitis and/or encephalitis in both immunosuppressive
and immunocompetent individuals [1]. In some cases, infection with HSV-1 or 2
have also been reported to be associated with the acute retinal necrosis syndrome
[8].
Presently the therapeutic agents used for treating acute keratitis include the
administration

of

antivirals

and

corticosteroids

and

non-steroidal

anti-

inflammatory drugs such as Cyclooxygenase-2 (COX-2) blockers [7, 9, 10].
Prolonged use of antivirals was shown to result in the development of resistance
particularly in immunocompromised individuals [11, 12]. Similarly use of
corticosteroids might give rise to numerous adverse effects [13, 14] and in some
patients it may exacerbate HSK lesions due to enhanced HSV-1 replication [15].
Animal studies in the mouse model of HSK have demonstrated that cytokine and
3

chemokine blockers such as the IL-1 receptor antagonist are effective [16]. As
neovascularization is an essential event for HSK pathogenesis, siRNA against
VEGF was shown to be effective in reducing HSK lesions in the mouse [17].
Furthermore, mouse model studies also support the effectiveness of regulatory T
cell therapy in controlling HSK immunopathology [18].
In addition to topical and systemic administration of above mentioned
drugs, several prophylactic vaccination strategies also are being developed to
increase the cell mediated protection against HSV. Plasmid DNA encoding viral
antigens such as gD and /or gB [19-22] and live virus mutants such as vhs-/ICP8HSV strain have been shown to reduce the incidence of HSK [23-25]. They also
reduced ocular viral shedding and raise the level of neutralizing antibodies in
infected animals [25]. Subunit vaccines (gB2+gD2) are also shown to be useful in
controlling recurrent shredding and incidence of HSK in latently infected rabbits
[26].

Although several clinical trials are being conducted for different HSV

vaccines, such as gB2/gD2 by Chiron, gD2 MPL by Glaxo SmithKline (GSK) for
HSV-2, with many more in use, only one therapeutic vaccine for herpes simplex
keratitis in human has been reported [27]. Effective vaccines against HSV-2 could
even help reduce the incidence of neonatal ocular herpes. Approaches such as
intranasal/subconjunctival/topical routes of vaccination [20, 26], addition of
specific cytokines and chemokines [22, 28] to vaccine or use of an appropriate
immune modifier like CpG [29, 30] are under investigation to increase the efficacy
of vaccines against HSV. As the antivirals fail to prevent establishment of latency,
designing an effective vaccine is important to prevent recurrent ocular diseases.
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Thus further studies of immune mechanisms involved in the neurological
surveillance and its use in therapeutic vaccine designing is important.
MURINE HERPETIC SK MODEL
Study of the pathogenesis of human HSK from clinical observations, occasional
biopsy samples and transplant material is difficult. In the earlier literature, most of
the studies on HSK were performed on rabbits but currently the murine model is
mostly used to understand SK pathogenesis. Primary ocular HSV infection in mice
results in a stromal inflammatory response resembling human SK. Several strains
of mice (BALB/c, CAL-20, 129/SVEV, C57BL/6) and HSV-1 (RE, KOS, McRae
and F) strain are employed for HSK studies [7].
Primary infection of immunocompetent mice with HSV-1RE results in the
initial replication of virus in the corneal epithelium for 5-6 days with minimal
involvement of the stromal or other anterior segment tissues. Viral gene expression
as judged by mRNA are undetectable after 7-8 days p.i., however, viral DNA
could be detected in the cornea till day 20 p.i. At this initial replication phase, the
clinical SK lesions and other signs of inflammation are barely visible. However,
new blood vessels sprouting from the limbus and histologicaly inflammatory
events are evident within few hours of infection (Fig .1) (All figures and tables are
located in the appendices). This early stage of lesion development is usually
referred to as preclinical phase of SK.
Inflammatory cells
Toll-like receptors expressed on innate immune cells form a critical component of
host surveillance system. Triggering of these pattern recognition receptors
activates the transcription factor NFκ that causes the induction of cytokines and
5

chemokines in response to the pathogen associated molecular patterns (PAMP)
[31]. This initial induction of inflammatory genes could lead to the development of
immunopathological lesions [31]. Components of HSV have been shown to
possess TLR2 and -9 ligand activity [32, 33]. Human and mice corneas were
shown to express different functional TLRs and there is accumulating evidence
that suggests TLRs could be involved in the HSK pathogenesis [34-36]. Virus
infection in the corneal epithelium, probably by its PAMP activity, initiates several
humoral and cellular immune responses that together are responsible for clearing
the infection [31]. As summarized in Fig 1., early inflammatory response that is
evident in the underlying stroma mainly consisted of the PMNs [37]. This
infiltration starts as early as 18 hr post infection (p.i.) peaking at around 48 hr and
then declines by 5 days p.i [37]. This initial pattern of PMN influx correlates with
the presence of replicating virus and thought to be involved in controlling virus
spread [37, 38]. Thus, PMN depletion with specific monoclonal antibodies (mAb)
before infection results in delayed virus clearance from the cornea. Although it is
not known how the PMNs infiltrating to the stroma could clear the virus from the
epithelium, however, it has been proposed that TNF-α, nitric oxide and other
reactive oxygen metabolites could be involved in this process. Degranulation of
PMNs results in the release of inflammatory mediators such as IL-1β, TNF-α, IL12, preformed vascular endothelial growth factor (VEGF) and tissue degrading
enzyme metalloproteinase-9 (MMP-9) required to break down the stromal matrix
which are critical to drive the subsequent tissue destructive events that ultimately
lead to HSK [39-42] (Fig. 2).
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Although the early inflammatory phase of ocular HSV infection is
dominated by PMNs, other cells such as macrophages [43], dendritic cells (DC)
[44, 45] natural killer (NK) cells [46, 47] and γδ T cells [48] were shown to
participate in virus clearance and act as a source of cytokines and chemokines in
the infected cornea [43, 46]. Macrophages also act as a source of angiogenic
factors VEGF, FGF as well as angiogenic CXC chemokine [49]. In addition to
these cells, Langerhans DCs also invade the corneal tissues most likely from the
conjunctiva [44, 45]. Apart from acting as a source of cytokines, their major role is
to carry the viral antigens to the draining lymph nodes and by which they
accelerate the immunopathogenesis of HSK by influencing the generation of an
adaptive immune response. But recent studies in skin infection model question the
role of Langerhans DCs in antigen presentation and suggest that special subsets of
migratory DCs could be involved in carrying the viral antigen to the local draining
lymph nodes [50, 51].
Cytokines and Chemokines
Multiple cytokines and chemokine transcripts are expressed early after HSV
infection (around 6 hr p.i). Most prominent are IL-1 and IL-6 those are shown to
be critical to initiate the subsequent cascade of inflammatory events [52, 53].
Although after infection, most of the host genes are turned off [54], infected
epithelial cells can still act as the initial source of IL-1 and IL-6 [55-57]. TLR2 and
to a lesser extent TLR9 ligand activity of HSV and other endogenous TLR ligands
could play critical role in initiating this cytokine and chemokine release [35].
Accordingly, mice lacking TLR2 and the adapter molecule MyD88 had reduced
levels of IL-1, IL-6 and MIP-2 in their corneas post infection [35]. Cytokines
7

released from the infected cells as a result of stimulation through PAMPs could
drive the expression of other key mediators from uninfected cells. Thus, IL-1 can
trigger IL-6 production from uninfected cells [59] which is known to trigger
macrophage inflammatory protein (MIP-2) (CXCL8), a critical chemo attractant
for PMNs [60, 61]. Initial IL-1 production could trigger the upregulation of COX2 that could help in the synthesis of proinflammatory prostanoides such as
prostaglandin E2 (PGE2) [10]. Even TLR ligand activity were shown to be
involved in the expression of COX-2 in the infiltrating inflammatory cells but it is
not yet clear whether it is a direct effect or caused by the cytokines released
through TLR stimulation [35]. Another important cytokine that is upregulated in
HSV infected cornea is TNF-α [62, 63]. Recent studies show that mice unable to
produce TNF-α have higher viral titers in the cornea and are more susceptible to
lesion development [62].
In addition to the above list of cytokines, another cytokine that is pivotal
for the pathogenesis of SK is IL-12, but the trigger for early IL-12 release is yet to
be identified [64, 65]. The PMNs, macrophages and Langerhans DCs those
infiltrating into the cornea are the likely sources of IL-12 [40, 66]. One of the
critical downstream events of IL-12 is the production of IFN-γ from cells like
macrophage, NK cells and neutrophils that express IL-12 receptor on their surface.
Previous reports show the role of STAT-4 signaling pathway in the production of
IFN-γ following IL-12 stimulation [67]. IFN-γ is shown to play several important
roles in HSK pathogenesis and those include, aiding PMN influx by up regulating
PECAM-1 (Platelet cell adhesion molecule-1) [68], and upregulation of ICAM-1
on the corneal epithelium [69], endothelium and keratocytes needed for
8

extravasation of inflammatory cells. It also upregulates MHC-II on antigen
presenting cells (APCs) those are involved in the induction of pathogenic CD4+ T
cells in the draining lymph nodes [70, 71]. In addition, IFN-γ was also shown to
modulate HSK lesions by inducing angiostatic chemokines such as IP-10
(CXCL10) [72].
Another cytokine that has currently received much attention in CD4+ T cell
mediated immunopathology and autoimmune diseases is IL-17 [73]. IL-17 is
produced by CD4+ T cells (Th17 cells) and was shown to influence the infiltration
of PMNs by up regulating IL-6 and IL-8 [74]. Recent studies suggest that IL-17
could influence the early neutrophil influx into the HSV infected corneas and,
thus, could have a role in HSK pathogenesis [75]. Recently, the ability of CD4+ T
cells to produce IL-17 was shown to be regulated by MyD88 dependant TLR
pathway[76]. This issue needs to be investigated in HSK. IL-23 that it is essential
for the maintenance of Th17 cells was shown to be upregulated post ocular HSV
infection [77]. According to the recent findings, apart from maintaining Th17
producers, IL-23 could be involved in balancing the production of IL-12 in the
system. Thus, mice lacking the IL-23 produced more IL-12 and IFN-γ and showed
heightened susceptibility to HSK [77].
Apart from the proinflammatory cytokines, HSV infection also induces
several anti-inflammatory cytokines such as IL-10 and TGF-β in the infected
corneas. IL-10 was shown to be important in minimizing SK lesion severity. Thus
mice deficient in IL-10 gene demonstrate a more susceptible phenotype as
compared to the IL-10 sufficient animals [78]. Additionally, a higher level of IL-
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10 was also observed in the infected corneas during the resolution phage of SK
[79].
Along with several cytokines, ocular infection with HSV also upregulated
several chemokines such as MIP-2, KC (CXCL3), MCP-1 (CCL-2), RANTES
(CCL-5), IP-10, MIP-3α (CCL20) [80-82]. These may aid in the influx of
inflammatory cells into the corneal stroma. Among these MIP-2 and KC were
shown to be predominant and are critical for the early PMN infiltration [60].
Induction stimuli for these chemokines seem to be the proinflammatory cytokines
released as a result of virus replication in the corneal epithelium. Corneal epithelial
and stromal cells were shown to produce CCL20 following the stimulation with
TNF-α and IL-1β [82]. In addition TLR ligand activity of the HSV could also be
involved in the induction of these chemokines [35]. Another group of chemokines
expressed in the late preclinical phase are MIP-1α (CCL3) and lymphotactin
(XCL1) [80]. Although the stimuli for the upregulation of these chemokines are
not known, these chemokines are pivotal for the infiltration of CD4+ T cells in the
clinical phase of the HSK lesions.
Neovascularization
One of the necessary steps in the immunopathology of HSK is the development of
new blood vessels post infection in normally avascular corneas [83] as the newly
formed blood vessels could help in the infiltration of inflammatory cells. New
blood vessels start sprouting from the limbal vessels by day 1 p.i. reaching the
central cornea by day 20 p.i. [84]. Inflammatory cells escape from these highly
permeable blood vessels that result in corneal haze and vision impairment. Ocular
HSV infection results in the upregulation of several angiogenic factors such as
10

VEGF, bFGF, MMP-9 and E-L-R motif containing chemokines [42, 80, 84, 85].
VEGF mediated angiogenesis is a prominent and early event in HSK with VEGF
transcripts detectable by 12 hr p.i. and protein by 24 hr p.i. [84]. Uninfected
corneal epithelial cells and stromal cells act as the initial source of VEGF and
subsequently, it is released by the infiltrating inflammatory cells such as PMNs
and macrophages [84]. Evidence suggests that proinflammatory cytokines
generated early after infection such as IL-1 and IL-6 could stimulate the
production of VEGF [86-88]. Additionally, HSV DNA, rich in CpG motif can
induce IL-1 and IL-6 with its TLR9 ligand activity that in turn could induce VEGF
production

[89].

Another

critical

factor

involved

in

the

process

of

neovascularization is the collagenase MMP-9 [42]. PMNs and corneal epithelial
cells are shown to produce MMP-9 in response to inflammatory cytokines such as
IL-1 and TNF-α [90]. Apart from cytokines, chemokines with E-L-R motifs such
as MIP-2 are also known to induce ocular angiogenesis [91]. While several
proinflammatory cytokines and chemokines were shown to induce corneal
neovascularization, IL-12 and IL-18 are shown to inhibit angiogenesis by
downregulation of VEGF production [72, 92]. Inhibition of angiogenesis by using
siRNA

against

MMP-9

and

VEGF

were

shown

to

reduce

corneal

neovascularization and HSK lesion severity in a mouse model [17]. Thus,
modulation of angiogenic factors could prove to be beneficial in the therapy of SK.
Clinical Stromal Keratitis
Soon after the early inflammatory events including the clearance of replicating
virus and viral antigens, around day 6 and 7 p.i., lymphocytes and other
inflammatory cells infiltrate into the corneal stroma leading to the development of
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clinically evident SK lesion [93]. Interestingly, although at other inflammatory
sites, such as TG, higher frequencies of CD8+ T cells are observed but in infected
corneas CD4+ T cells greatly outnumber the CD8+ T cells [94]. Most of the cells
infiltrating into cornea express the critical homing marker VLA-4 and chemokine
receptor CCR5 (MIP-1α [58, 95]. The range of antigens that are recognized by
these infiltrating CD4+ T cells still remain unknown and the role of viral antigens
in driving virus specific CD4+ T cells in HSK needs further investigation.
Interestingly, in TCR transgenic animals with SCID/ RAG background that could
not recognize viral antigens, it is possible to induce lesions with a replication
competent virus [96, 97]. These observations suggest that probably the
inflammatory events following HSV infection could result in unmasking of the
corneal autoantigens [2]. Few other observations also suggest that virus specific
CD4+ T cells may crossreact with corneal antigens and could contribute to HSK
pathogenesis. Support for this hypothesis comes from Cantor’s lab where they
showed that the UL-6 protein from HSV acts as a molecular mimic for a corneal
autopeptide [98]. The role of molecular mimicry still needs further confirmation.
Alternately, bystander activation of T cells in a non TCR mediated manner by the
inflammatory molecules produced as a result of ocular HSV infection could
explain HSK pathogenesis. Although not explained mechanistically, the
observation that it is possible to induce SK in the mouse whose T cells are
genetically incapable of recognizing viral antigen could support the involvement
of bystander mechanisms [99, 100]. In this system cells dying of HSV infection
were responsible for inducing cytokine production [100, 101].
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Another subset of T lymphocytes that infiltrate the cornea is the
CD4+CD25+Foxp3+ Treg cells.

In addition to other mechanisms such as the

cytokine IL-10 [102], Treg are shown to be involved in controlling the ongoing
inflammatory processes in the cornea [95]. In addition, these cells might help in
the resolution of the clinical lesions. Studies suggest that depletion of Treg from
the mice prior to infection results in more severe SK lesions [95]. Different
mechanisms involved in the suppressive activity of Treg are release of cytokines
IL-10, IL-35 and TGF-β, direct contact with effectors and APCs etc. [102, 103],
but the mechanism and the site of Treg activity in HSK is controversial and need
further investigations. The fact that even in IL-10-/- animals have functional Tregs
and that depletion of Tregs in IL-10-/- animals could increase the lesion severity
suggests that Tregs and IL-10 are two independent anti-inflammatory mechanisms
in HSK [104].
CONCLUSION
Currently several therapeutic and prophylactic drugs are being used for the
treatment of SK. Discovery of new molecular participants in the pathogenesis of
SK will show new targets for designing better therapeutic drugs. Study in mouse
model shows a role of TLR2 and TLR9 signaling in HSK. Even in human HSK
corneas, changes in the expression levels of several TLRs are being noticed [35,
36]. What is not yet known is under physiological condition how such a small
amount of virus could trigger the TLRs. Better understanding of the signaling
processes, induction of critical inflammatory molecules and their appropriate
modulation could help in finding cure for SK. Similarly, anti-inflammatory
mechanisms such as induction of IL-10 and regulatory T cell could be beneficial in
13

the prevention as well as resolution of SK lesions. Therefore, several drugs and
reagents such as FTY720, retinoic acid, galactin-9 [105-107] those are capable of
inducing regulatory T cells or IL-10 could be useful therapeutic strategies to
suppress SK lesion severity. These approaches could be used as single or in
combination with other existing therapies for better result and less side effect.
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Figure. 1. Principal events in herpetic SK pathogenesis
Following ocular HSV infection replicating virus could be detected in the cornea
till 5-7 days p.i. Early inflammatory response in the cornea is dominated by the
polymorphonuclear leukocytes (PMN). Infiltration of PMNs into the cornea is be
characterized by a typical biphasic influx. Angiogenesis or the process of new
blood vessel development from the existing limbal vessels starts at 24h p.i. and
peaks around 15 days p.i. Influx of pathogenic CD4+ T lymphocytes occurs in the
clinical phase around 7-9 days p.i.
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Figure. 2 Schematic representation of the early events in the SK cornea
HSV-1 with its TLR 2 and TLR9 ligand activity induces numerous
proinflammatory cytokine and chemokines early after infection of corneal
epithelium. These cytokines and chemokines in turn help in the influx of
inflammatory cells such as PMNs, macrophages, NK cells and dendritic cells into
the infected corneas. Presence of inflammatory cells and the production of more
inflammatory mediators and the angiogenic factors help in creating favorable
conditions for the subsequent events that lead to the clinical phase. Development
of new blood vessels from the exiting limbal vessels also helps in the influx of
inflammatory cells into the corneal stroma in the clinical phase of SK.

33

Part-II
Innate recognition network driving the HSV
induced corneal immunopathology: role of toll
pathway in the early inflammatory events in
stromal keratitis
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Research described in this chapter is a modified version of an article published in
2007 in The Journal of Virology by Pranita P Sarangi, Bumseok Kim, Evelyn
Kurt-Jones and Barry T Rouse.

Sarangi PP, Kim B., Kurt-Jones E, Rouse BT. Innate recognition network driving
the HSV induced corneal immunopathology: Role of Toll Pathway in the early
inflammatory events in Stromal Keratitis. J Virol. 2007. Oct; 81(20):11128-3.
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In this chapter “our” and “we” refers to me and co-authors. My contribution in the
paper includes (1) Selection of the topic (2) Compiling and interpretation of the
literature (3) Designing experiments (4) understanding the literature and
interpretation of the results (5) providing comprehensible structure to the paper (6)
Preparation of graphs, figures and tables (7) Writing and editing
Abstract
Ocular infection with herpes simplex virus (HSV) sets off an array of
events that succeed in clearing virus from the cornea but leaves the tissue with a
CD4+ T cell orchestrated chronic inflammatory lesion that impairs vision. We
demonstrate that Toll-like receptor (TLR) signaling forms a part of the recognition
system that induces the syndrome that eventually culminates in immunopathology.
Accordingly, in a comparison of the outcome of the infection in wild-type (WT)
mice and those lacking TLR function it was apparent that the absence of TLR2,
and to a lesser extent TLR9, resulted in significantly diminished lesions. Similarly
mice lacking the adapter molecule MyD88 were resistant to lesion development
but such animals were also unable to control infection with most succumbing to
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lethal encephalitis. The susceptibility of TLR4-/- animals was also evaluated.
These animals developed lesions more rapidly that were more severe than in WT
animals. We discuss the possible mechanisms by which early recognition of HSV
constituents impact on the subsequent development of immunopathological
lesions.
Introduction
Viruses induce several immediate host reactive events that impact on the
long term consequences of infection. For example, ocular infection of mice with
herpes simplex virus (HSV) causes a multitude of cytokine, chemokine and
cellular changes to occur [1]. Manipulating the expression of many of these affects
the severity of the subsequent vision impairing consequences such as
neovascularization and chronic inflammation [2-5]. The latter reaction is
immunopathological set off initially by infection, but sustained well after
replication has ceased and viral antigens are removed [1]. These stromal keratitis
(SK) reactions occur in response to HSV in humans and represent the commonest
cause of infectious blindness in developed countries [6].
We know that viruses and their components can trigger multiple innate
immune protective and inflammatory responses [7]. These include interferon
induction, the production of multiple cytokines, and activation of complement as
well as innate cellular defenses [7, 8]. Recognition mechanisms that initiate and
control innate reactions to viruses remain poorly understood but accumulating
evidence indicates that membrane bound cell surface or intracellular toll-like
receptors (TLRs) form part of the surveillance system [9]. After the initial
observation with respiratory syncytial virus [10], several viruses were shown to
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express ligand activities for one or more TLRs [9]. Infection could also result in
the release and induction of host molecules such as heat shock proteins that may
themselves activate TLRs and so contribute to the innate response [11, 12]. The
observation that TLRs participate during HSV infection came from several lines of
investigation. Initially purified HSV DNA like synthetic CpG DNA, the ligand for
TLR9 [13], was shown to induce ocular neovascularization, an essential step in the
pathogenesis of SK [14]. HSV DNA was later confirmed to possess TLR9 ligand
activity [15] and studies in knockout mice revealed a role for TLR9 in HSV
induced type I interferon production [13]. Other investigations demonstrated that
HSV also possesses TLR2 activity [16] with mice lacking TLR2 showing higher
resistance to lethal HSV encephalitis than WT animals [16]. This perhaps
unexpected observation that brain inflammation and death were reduced in the
absence of TLR2 (but virus levels were similar in WT and TLR2-/- mice)
indicated that encephalitis, the usual cause of death with HSV infection, was the
consequence of the virus acting as a TLR2 ligand driving an inflammatory reaction
in the brain [16]. In addition to inflammatory processes, herpetic encephalitis,
especially in humans may represent a direct destructive effect of the virus [17] and
even in mice neurovirulence appears associated with the success of virus gaining
access to and replicating in the CNS [18]. Thus both viral and host components
may contribute to disease pathogenesis.
In the present report, we measured the influence of TLR2 and other
potential TLR ligand effects of HSV in a corneal scarification disease model
where lesion expression is widely agreed to represent a host immunopathological
response [1]. In this model, animals lacking lymphocytes fail to develop SK
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lesions and in fact die of herpetic encephalitis with an abundance of virus in the
brain [19]. We examined the sequence of events that occurred following infection
of different TLR knockout mice compared to WT animals. Our results demonstrate
that TLR2-/-, MyD88-/- and to a lesser extent TLR9-/-, but not TLR4-/-, mice
showed significantly reduced SK lesions upon HSV infection. Similarly, TLR2-/and MyD88-/- mice also showed reduced neovascularization as compared to other
groups. These latter strains also showed marked reduction in early non lymphoid
inflammatory infiltrates as well as lower levels of proinflammatory cytokines
compared to WT or TLR4-/- animals. In addition, whereas both TLR2-/- and
TLR9-/- animals resisted the lethal effects of HSV, most MyD88-/- animals
infected with the same dose succumbed to lethal disease. The TLR4-/- animals
developed lesions more rapidly that were more sever than in WT animals. We
discuss the possible mechanisms by which early recognition of HSV constituents
impacts on the subsequent development of immunopathological lesions.
Materials and methods
Animals.
TLR2-/- ,TLR4-/-, TLR9-/-, TLR2/4d-/-, MyD88-/- mice were the kind gift of Dr
S Akira, (Osaka University, Osaka) and were backbred for more than 10
generations onto the C57BL/6 background. Backbreeding was confirmed by
examining a 110 marker panel that distinguishes between C57BL/6 and 129
(Charles River Laboratories). These microsattelite markers are spread across the
19 autosomes and the X chromosome at approximately 15cM intervals. C57BL/6
mice were obtained from Harlan Sprague-Dawley, (Indianapolis IN). All
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experimental procedures followed the guidelines the Association for Research in
Vision and Ophthalmology resolution on the use of animals in research.
Corneal HSV-1 infection and clinical observation
HSV-1 strain RE was used in all procedures. Details of corneal infections of mice
under deep anesthesia were described in a previous publication [20]. Animals were
infected with a range of virus doses although most of the reported experiments
mice were infected with 5×103 pfu/eye. The experiments were repeated multiple
times especially the comparison of TLR2-/- with control animals. Lesion scores
and the extent of angiogenesis were measured at various times post infection as
described in detail previously [21, 22].
Histopathology
For histopathologic analysis, eyes from different groups of mice were extirpated at
the indicated time point p.i. and snap-frozen in OCT compound (Miles, Elkart,
IN). Six micron thick sections were cut and air dried in a desiccation box. Staining
was performed with hematoxylin and eosin (Richard Allen Scientific, Kalamazoo,
MI).
Flow Cytometry.
For flow cytometry measurement of the infiltrating cells, four corneas or two
trigeminal ganglias (TGs) were collected per time point. Corneas or TGs were
digested in liberase (Roche Diagnostics Co., Indianapolis, IN) for 45 min at 37oC.
Single cell suspension was prepared as described elsewhere [23]. The Fc receptors
were blocked with unconjugated anti CD16/32 (BD Pharmingen, San Diego, CA)
for 30 min. Samples were incubated with fluorescein isothiocyanate (FITC)
labeled anti Gr-1, anti CD11b, anti CD11c (BD Pharmingen), F4/80 (eBioscience),
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or anti CD4 (BD Pharmingen), antibody for 30 min. For intracellular staining for
(Cyclooxygenase-2) COX-2, goat anti COX-2 and Donkey anti goat IgG were
used as primary and secondary antibody (Santa Cruz Biotechnology, Santa Cruz,
CA) respectively. For detection of induced Hsp-70, FITC conjugated Hsp70
(Hsp72) antibody was obtained from Stressgen (Ann Arbor, Michigan). FITC
conjugated Rat IgG was used as isotype control for Hsp-70. Intracellular staining
for COX-2 and Hsp70 was performed using Fixation/Permeabilization Solution
Kit with BD GolgiPlug (BD Bioscience). All samples were collected on a
FACScan (BD Biosciences, San Diego, CA), and data were analyzed by using cell
Quest 3.1 software (BD Biosciences).
Cytokine and chemokine ELISA of corneal lysate
For preparation of corneal lysates, six corneas per indicated time point were
pooled from each group of mice and were processed as described previously [20].
For draining lymph nodes (DLNs), cervical lymph nodes from each mouse were
collected and processed. Levels of IL-6, IL-1β, Macrophage Inflammatory Protein2 (MIP-2) and Vascular Endothelial Growth Factor (VEGF), IL-10 in corneal
lysates and IL-10, IL-6, IFN-γ in DLN lysates were determined by a standard
sandwich enzyme-linked immunosorbent assay (ELISA) protocol. Anti IL-6, anti
IL-10, anti IFN-γ capture and detection antibodies were purchased from BD
Pharmingen. Anti IL-1β, anti-MIP-2, anti VEGF capture and biotinylated detection
antibodies were purchased from R&D Systems (Minneapolis, MN). The color
reaction was developed using ABTS (Sigma-Aldrich, St. Louis, MO) and
measured with an ELISA reader (Spectramax 340; Molecular Devices, Sunnyvale,
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CA) at 405 nm. Quantification was performed with Spectramax ELISA reader
software version 1.2.
Reverse Transcription and real time PCR
Total RNA from naïve and infected C57BL/6 corneas and DC2.4 cell line were
isolated at different days p.i. by using RNAeasy kit (QIAGEN, RNeasy MinElute
Cleanup Kit) and was reverse transcribed by using Murine Leukemia Virus reverse
transcriptase (Life Technologies, Bethesda, MD) with oligo (dT) as the primer
(Invitrogen, San Diego, CA). All cDNA were divided into aliquots and stored at 20oC until further use. All murine DCs express TLR2, 4 and 9 as did the DC2.4
cell line (Dendritic cell line, obtained from Dr K.L. Rock). PCR was performed in
a PTC-100 programmable thermal controller (MJ Research, Cambridge, MA)
using Hot start PCR Master mix (Promega, Madison, WI). The primers used were
murine GAPDH forward (CATCCTGCACCACCAACTGCTTAG) and reverse
(GCCTGCTTCACCACCTTCTTGATG),

murine

(AAGAGGAAGCCCAAGAAAGC)

TLR2

and

(CGATGGAATCGATGATGTTG),

murine

(ACCTGGCTGGTTTACACGTC)

reverse
TLR4

and

(CTGCCAGAGACATTGCAGAA),

murine

(ACTGAGCACCCCTGCTTCTA)

forward
reverse

TLR9
and

forward

forward
reverse

(AGATTAGTCAGCGGCAGGAA).
Real-time PCR was performed using an iQ5 Real-Time PCR Detection
System (Bio-Rad). PCR was performed using SYBR Green PCR Master Mix
(Applied Biosystems), according to manufacturer’s protocol. PCR amplification of
housekeeping gene, murine HPRT, was done for each sample as a control for
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sample loading and to allow normalization between samples. The primers used
were

murine

HPRT

forward

(GACCGGTCCCGTCATGC)

and

reverse

(TCATAACCTGGTTCATCATCGC), murine β-defensin 2 (mBD-2) forward
(TATGCTGCCTCCTTTTCTCA) and reverse (GACTTCCATGTGCTTCCTTC),
murine β-defensin 3 (mBD-3) forward (CTCCTGGTGCTGCTGTCTCCAC) and
reverse (AACTCCACAACTGCCAATCTGA).
Virus recovery and titrations
Eye swabs were taken from infected corneas (four eyes/group) using sterile swabs
at the indicated time points. Similarly, brain tissue and TG were taken out from the
infected animals at the indicated time points (N=3). The tissues were disrupted by
homogenization in 1 ml ground glass grinders (Wheaton) and centrifuged, and the
supernatant was used to assay viral titers. and was the titration was performed by
standard plaque assay as described previously [20].Titers were calculated as log10
pfu/ml as per standard protocol [24].
Statistical Analysis
Statistical significance was determined by Student's t test. P < 0.05 was regarded
as a significant difference between the groups.
Results
Expression of TLRs and TLR ligands in the naive and infected corneas
Since HSV replication in the eye occurs almost exclusively in corneal
epithelial cells

[1], the expression of TLRs in corneal buttons taken from

uninfected eyes was examined by RT-PCR for the presence of TLR2, 4 and 9
mRNA. All could be demonstrated (Fig.1A). Whereas previous reports had shown
that both TLR2 and TLR9 activating ligands are expressed by HSV [25],
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endogenous TLR ligands might also be induced and released from dead or dying
cells following infection [11, 12]. As shown in Fig1B, the TLR4 ligand, inducible
Hsp70 [11] could be demonstrated in corneal tissues in samples analyzed at 24 h
post HSV infection. Similarly, as shown in Fig1C, both β-defensin2 and βdefensin3 mRNA expression was increased in the infected as compared to the
naïve corneas of which and β-defensin3 has been shown to trigger TLR4 [26].
Hence TLR4 as well as previously demonstrated TLR2 and TLR9 ligand effects
could be involved in the recognition events following ocular HSV infection.
Disease expression following HSV infection in control and knockout mice
To determine the role of TLRs in HSV pathogenesis in the eye, TLR
knockout mice that were fully backbred onto the C57BL/6 background were
ocularly infected with different doses of HSV-1 RE and evaluated over a 15-20
day time period to quantify the extent of corneal neovascularization as well as the
severity of SK. At infection doses of 2 × 105 pfu/eye or above all groups
developed lesions and neovascularization responses that were similar in
magnitude. However, significantly different responses in the various groups
became evident at infection doses of 2 × 104 and below. Fig. 2 shows the results of
1 of 2 experiments in which the animals were infected with 5 × 103 pfu virus. As is
evident, at both days 8 and 15 p.i., both the TLR2-/- and MyD88-/- animals
showed significantly diminished lesions as well as neovascularization compared to
WT animals. For instance, where as almost 90% of control WT animals developed
SK lesions with a severity score of 3 or greater and neovascularization scores of 8
or greater, in TLR2-/- and MyD88-/- animals only around 30% of animals had
such severity scores. Moreover at the peak response time (day15 p.i.) the mean
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severity scores in TLR2-/- and MyD88-/- were 1.5 ± 0.37 and 1.8 ± 0.4
respectively which were significantly (p ≤ 0.005) less than those observed in WT
mice (3.8 ± 0.26). On average the mean severity of SK in TLR2-/- was 60%
reduced over controls at day 8 p.i. and was further reduced to 65% by day 15 p.i.
These experiments indicate that animals unable to respond to the TLR2 ligand
activity of HSV showed a resistant phenotype. However curiously, both TLR2-/and MyD88-/- animals often showed quite severe herpetic periocular disease, a
lesion seldom seen in the WT animals at the low dose of virus used.
Animals lacking TLR9 also showed more resistance to HSV induced SK
and neovscularization than WT animals although differences were modest and
only significantly reduced with the 15 day scores (2.7 ± 0.38 compared to 3.8 ±
0.26, p=0.03) (Fig. 2). Most of the TLR9-/- animals also developed herpetic
periocular disease but lesions were less intense than those noted in TLR2-/- and
MyD88-/- animals.
The pattern of response in TLR4-/- animals revealed a modestly more
susceptible phenotype. Thus by day 8 p.i., 30% of TLR4-/- showed level 3 lesions
(mean, 2.3 ± 0.13) whereas almost all WT animals lacked lesions at this time point
(mean, 1.2 ± 0.15, p = 0.004). The neovascularization score reflected a similar
heightened susceptibility of TLR4-/- (mean, 7 ± 0.5) compared to WT animals
(mean, 4.5 ± 0.4, p =0.009) (Fig. 2). Curiously, animals lacking both TLR2 and 4
responsiveness showed a resistance phenotype although this was less in magnitude
compared to TLR2 or MyD88 knockout animals.
MyD88 is an essential downstream adapter of TLR signaling, particularly
for TLR2 and TLR9 responses [27]. TLR4 also signals via MyD88 but can
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activate an alternate pathway of MyD88-independent gene expression [28].
Interestingly, although the MyD88-/- animals showed a resistant phenotype to
disease expression similar to the TLR2-/- mice, the MyD88-/- animals were far
more susceptible to the lethal effects of HSV infection. As shown in table. 1, even
at the 5 ×103 pfu dose, up to 70 % of the infected MyD88-/- animals were dying by
day15 p.i. although almost 60 % of them showed no signs of clinical disease. The
animals were presumed to be dying from viral encephalitis and replicating virus
could be demonstrated in the homogenates of brain tissue harvested from
moribund MyD88-/- animals (Table. 2). Thus, eliminating signaling through
multiple TLRs by knocking out MyD88 reduces local inflammation but may allow
enhanced viral replication and/or spread, while eliminating single TLRs, i.e.,
TLR2 or TLR9, ameliorates local immune pathology but these receptors may be
redundant for control of virus replication/spread.
As shown in table. 1, both at 2 ×104 pfu/eye and 5 ×103 pfu/eye of
infection, neither TLR2-/- nor TLR9-/- animals were more susceptible to lethal
infection as were WT animals. In addition to brain and TGs, virus titers were also
measured in eye swabs collected from infected cornea. As shown in table3, in
contrast to CNS, virus titers did not increase in the absence of TLRs or MyD88-/in the corneas and all of the groups could clear the virus efficiently by day7 p.i.
Our data confirms the previous finding by others that

MyD88 independent

antiviral mechanisms can effectively compensate for the absence of MyD88 in a
localized HSV-1 infection [13]
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Cellular differences between control and knock out animals
Soon after HSV infection of the corneal epithelium, cytokine expression
and cellular changes occur [1]. One prominent event is infiltration in the
underlying stroma by mainly neutrophils [29]. The stimuli that induce such
responses remain to be identified but they appear to include chemokines such as
MIP-2 and MCP-1 induced directly or indirectly by HSV infection in the corneal
epithelium [1, 30]. Additionally, angiogenic molecules such as VEGF and IL-6 are
induced both of which play a role at causing the neovascularization of the cornea
[20, 31]. To compare the initial inflammatory response in knockout versus WT
control mice, tissue sections were examined. As is evident in Fig. 3, diminished
cell infiltrates at 48 h were apparent in TLR2-/- , MyD88-/- as well as in TLR9-/sections compared to WT controls. In the latters the inflammatory infiltrates had
fully accessed the central cornea, but in both TLR2-/- and TLR9-/- the infiltrates
were largely confined to the limbal region. Of these two TLR knockouts, the
infiltration of cells in TLR2-/- was far less than in TLR9-/- animals. Of interest,
the inflammatory events in TLR4-/- animals appeared slightly elevated as
compared to WT. This more severe reaction was also more evident by flow
cytometric analysis of Gr1+ and CD11b+ cells in the infected corneas (Fig. 3).
It has been documented by past studies that after ocular infection with
HSV, replicating virus could be detected in the TG for 2-7 days p.i. [32]. The
presence of virus in the TG induces a chronic inflammatory reaction involving
multiple cell types that is responsible for controlling the virus load as well as to
restricting the further spread of the virus [32]. Therefore, we examined the cells
from the TG of different groups at 48 h and 96 h p.i. by flow cytometry. A
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diminished inflammatory lesion was observed in the infected TGs in the TLR2-/and MyD88-/- as compared to wild type. As shown in Fig. 4, infiltration of Gr1+,
CD11b+, CD11c+ and F4/80+ cells was reduced in the TLR2-/- and MyD88-/animals. Interestingly, similar to the cornea, an increased inflammatory cell
number was noticed in the TLR4-/- animals as compared to WT controls.
Cytokine and other proinflammatory protein differences between control and
knock out animals
A likely explanation for the reduced influx of inflammatory cells and
eventual resistance to disease expression in TLR2-/- (and MyD88-/-) mice could
be a reduced proinflammatory cytokine/chemokine response to infection. Lysates
of corneas collected at 48 h and 96 h p.i. were used to measure the levels of
candidate molecules shown in previous studies to correlate with the outcome of
ocular HSV infection [1]. These were IL-6, MIP-2, and IL-1β, VEGF as well as
the enzyme COX-2. As shown in Fig. 5, compared to WT, a three- to four-fold
reduction in the levels of these proinflamatory mediators was evident in the lysates
of TLR2-/- and MyD88-/- corneas at 48 h and 96 h p.i. IL-6 and IL-1β, produced
from virus infected cells were shown to stimulate noninfected resident corneal
cells and other inflammatory cells in a paracrine manner to secrete VEGF, a potent
angiogenic factor [1]. Interestingly, a marked reduction was noticed in the level of
IL-1β and IL-6 and VEGF in the TLR2-/-, MyD88-/- mice. The TLR9-/- animals
had a moderate decrease in inflammatory mediators but this was only evident at
the 48 h time point. In contrast, TLR4-/- animals had slightly increased levels (2030 % elevated) of inflammatory mediators as compared to the WT controls at all
time points examined.
47

In two separate experiments the level of IL-10 induction in TLR4-/- mice
was compared to WT animals in both corneal extracts and the cervical DLN at
day2 and day5 after infection. As is evident in Fig. 6A, levels of IL-10 in the
corneas of TLR4-/- mice were less than observed in WT animals at both time
points accounting perhaps for the more severe reactions seen in TLR4-/- animals.
Although significant differences were not observed in the levels of IL-10 in DLN
at these time points (Fig. 6B), the levels of proinflammatory and Th1 cytokine, IL6 and IFN-γ were significantly higher (p ≤ 0.05) in TLR4-/- animals as compared
to WT (Fig. 6C and D). Interestingly, no difference was observed in the IL-10
levels in the DLNs of TLR-2-/- animals although the levels of IL-6 and IFN- γ
were lower in TLR2-/- as compared to WT animals (data not shown).
Previous studies had showed that, HSV infection of the cornea
upregulates the expression of COX-2, a critical enzyme for the induction of
potential inflammatory mediators such as prostaglandins [33, 34]. Moreover, the
administration of a selective COX-2 inhibitor diminished virus induced SK lesions
and neovascularization [35]. Recent in vitro findings had demonstrated that TLR2
signaling could induce COX-2 in peritoneal macrophages in vitro [36-38].
Therefore, we examined the role of TLR2 in HSV induced COX-2. Intracellular
staining revealed over 50% reduction in the percentage of COX-2 expressing cells
in HSV infected TLR2-/- mice corneas as compared to the WT and TLR4-/- mice
(Fig. 7A). In addition, reduced numbers of COX-2+Gr1+ cells was evident in the
TLR2-/- corneas as compared to WT (Fig. 7B). Interestingly, although there was
no difference in the percentage of COX-2 expressing cells in TLR4-/- animals as
compared to WT, such animals showed higher proportion of COX-2+Gr1+ cells as
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compared to WT animals (Fig. 7A and B). These results may mean that lower
induction of prostaglandins as well as chemokines could be a possible explanation
of the resistant and susceptible phenotype in TLR2-/- and TLR4-/- mice
respectively.
Discussion
Ocular infection with herpes simplex virus sets off an array of events that
succeed in clearing virus from the cornea but leaves the tissue with a CD4+ T cell
orchestrated chronic inflammatory lesion that impairs vision. We demonstrate that
TLR signaling forms a part of the recognition system that sets off a syndrome that
eventually culminates in immunopathology. Accordingly, in a comparison of the
outcome of the infection in WT mice and those lacking TLR function it was
apparent that the absence of TLR2, and to a lesser extent TLR9, resulted in
significantly diminished lesions. Similarly, mice lacking the adapter molecule
MyD88 were resistant to lesion development but such animals were also unable to
control infection and most succumbed to lethal encephalitis. Animals lacking
TLR4 developed lesions more rapidly and these became more severe than in WT
animals. It could be that modulating TLRs in an appropriate way could represent
an approach to control the severity of SK, an important cause of vision
impairment.
Past studies had demonstrated that HSV expresses at least 2 TLR ligand
activities [16]. These were for TLR2, perhaps a property of one of the envelope
major glycoproteins [25], and the TLR9 ligand activity of its DNA [15]. In this
report, we also show that HSV infection can cause cells to endogenously express
at least two molecules that act as TLR ligands. These were BD3, a TLR4 ligand
49

[26], and inducible Hsp70 ligand for TLR4 and perhaps also for TLR2 [11]. Our
investigations were designed to determine if the absence of TLR2, 4 and 9
impacted on the outcome of an immunopathological reaction in the eye that results
from HSV infection.
The most dramatic effects were observed when TLR2-/- mice were
infected with a low dose of a virulent strain of HSV. Compared to WT animals,
TLR2-/- mice showed considerable resistance to disease expression. Fewer eyes
showed

clinical

lesions,

and

those

that

did

had

reduced

levels

of

neovascularization and stromal inflammatory reactions at both the early and peak
times of the response. Reduced inflammatory reactions were also evident in the
trigeminal ganglion, a site where virus locates soon after ocular infection and
where virus persists when acute infection resolves [1]. Curiously, however, TLR2/- animals usually expressed notable periocular disease even when the eye itself
exhibited minimal or no lesions. We interpret these data to mean that the TLR2
ligand activity of HSV may be a major mechanism by which the virus, usually
confined to the epithelium of the infected cornea [1], induces early events
necessary for the development of the inflammatory disease. As shown in previous
studies, these include cytokines such as IL-6 and IL-1β and TNF-α [1], the
chemokine MIP-1α, MIP-2 [1], enzymes such as COX-2 associated with the
production of inflammatory molecules [1] and molecules responsible for
neovascularization of the usually avascular eye such as VEGF and MMP9 [1]. In
line with this, when levels of some of these molecules were measured early after
infection, all were reduced in amount in TLR2-/- compared to WT eyes. Evidence
that cells from TLR2 negative cells make reduced inflammatory cytokine
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responses to HSV was previously reported by others [16, 39]. Moreover, such
reduced inflammatory reactions in the brain to HSV were advocated to explain
why TLR2-/- mice were less susceptible to HSV encephalitis than were WT
controls [16]. Similarly in SK, the resistance phenotype of TLR2-/- animals is
likely explained by the reduced induction of key inflammatory mediators.
The observation that periocular disease was more severe in TLR2-/- mice
was less easy to explain especially since viral clearance kinetics in the eye itself
between TLR2-/- and WT showed no significant differences. Similarly, in the
brain, Kurt-Jones et al, observed no major differences in viral clearance between
control and resistant TLR2-/-animals [16]. Since the periocular lesions appear to
be caused by the virus itself, rather than being an immunopathological reaction,
conceivably the diminished stimulation of local antiviral molecules such as
interferons and perhaps others involved in the acute inflammatory response may
explain the outcome in TLR2-/- mice. We are further evaluating this issue.
Since HSV DNA is well known to act as a TLR9 ligand [13, 15], we
anticipated that TLR9-/- mice would also react differently to the ocular infection
than WT animals. Such TLR9-/- mice were in fact more refractory to lesion
expression than WT, but this was only a modest difference. This may be explained
by the possibility that the TLR9 ligand activity is inadequately produced under in
vivo infection conditions to drive the neovascular and inflammatory response, or
that any effect of TLR9 is largely overridden by the proinflammatory effect of the
TLR2 ligand activity of the virus. We hope to obtain double knockout mice to help
resolve these issues. Alternately, there could be reduced Th1 immune response in
the absence of TLR9 which could help reduce the lesion severity. We are currently
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investigating the generation of HSV specific immune responses in the absence of
specific TLRs.
Previous studies on herpetic encephalitis had not revealed a response
pattern phenotype for TLR4-/- animals. However, following ocular infection, such
animals were significantly, although not dramatically, more susceptible both to
neovascularization and SK lesion development. Lesions also occurred earlier than
in WT animals and a higher percentage of infected eyes developed lesions.
Periocular disease, however, was unusual as it is in WT animals. Although
currently we lack a definitive mechanistic explanation for these observations,
several ideas are being pursued. These include the possibility that the TLR4 ligand
activities might serve to either induce the production of anti-inflammatory
cytokines [40], or the induction of some type of regulatory T cell response [41], or
that the enhanced reactions occurred because of a heightened anti-HSV immune
response in TLR4-/- animals. Currently, we have preliminary support for at least
two of these ideas. Thus IL-10 levels in corneal extracts of TLR4-/- mice were less
than those present in WT control extracts (Fig. 6). Additionally, the magnitude of
T cell responses in TLR4-/- animal was marginally elevated over that of WT
animals (data not shown). We have yet to evaluate any differential induction of
regulatory T cell responses between TLR4-/- and control animals but such studies
are underway.
Our studies also included minimal investigations on the outcome of
infection in animals lacking both TLR2 and TLR4. Such animals also showed the
resistance phenotype but the magnitude was less than observed in TLR2-/- and
MyD88-/- animals. This could mean that the TLR2 ligand effect of the HSV is the
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dominant activity but this is partially blunted by the apparent anti-inflammatory
effect of TLR4 ligand stimulation. Perhaps the use of TLR4 ligands have some
place in the future therapy of SK.
Finally, our studies evaluated HSV induced ocular responses in MyD88-/mice. Such animals showed approximately the same phenotype as did the TLR2-/mice which may mean that TLR2 ligand mediated effects are the most significant
proinflammatory agonists with HSV infections. MyD88-/- mice, however, showed
one major response difference compared to TLR2-/- and other TLR-/- animals.
This was their marked susceptibility to herpetic encephalitis with animals usually
dying by 15 days p.i. Others have also observed that HSV may prove lethal to
MyD88-/- animals infected intranasaly [42]. The explanation for this heightened
susceptibility to encephalitis remains unclear. Accordingly, although virus was
cleared normally in MyD88-/- mice from the eye and TG, this was not true for the
brain where it persisted and was still present in dying animals. We anticipate that
the susceptibility of MyD88-/- animals might be explained by a deficiency in some
critical innate and/or adaptive immune responses that functions in the CNS. In
some other infection systems too MyD88-/- animals show reduced ability to
generate an effective adaptive immune response [43]. In our preliminary studies
we have noted that the antigen presenting cell function in MyD88-/- mice are
impaired which might have an effect on the generation of an effective immune
response.
In conclusion, our results indicate that the TLR ligand activity of HSV,
primarily TLR2, plays a role in the induction of an immunopathological response
in the cornea and TG. Other TLR ligands, such as TLR4, may serve to counteract
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the severity of the inflammatory response. It is conceivable that manipulation of
the TLR ligand response could provide a means to modulate SK lesions.
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Figure 1. Induced TLR ligands in the HSV infected corneas
A. Corneal buttons from uninfected mice were harvested and isolated total
mRNA was tested by RT-PCR for TLR2 and TLR4 and TLR9. All three
could be demonstrated in the naïve cornea. The DC2.4 cell line was used as
positive control.
B. Single-cell suspension of corneal cells was prepared from four corneas at
24 h p.i. Intracellular staining was done with FITC-labeled anti Hsp70
antibody as mentioned in the material and methods. The number of Hsp70
expressing cells was determined by FACS. Rat IgG was used as the isotype
control. The number on the upper-right corner represents the percentage of
Hsp70 cells/1×105 corneal cells at 24 h p.i.
C. C57BL/6 mice were infected with 2 × 104 pfu of HSV-1RE. At the
indicated time points, four corneas from infected mice were collected and
total mRNA was extracted. Real time PCR was performed to compare the
expression of mouse β-defensin-2 (mBD2) and mouse β-defensin-3 (mBD3) mRNA in the infected corneas at different time point p.i. as described in
material and methods. The bar diagram demonstrate the relative fold
increase in the expression of mBD2 and mBD3 as compared to naïve
cornea.
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Figure 2. Reduced SK lesions and neovascularization in TLR2-/-, TLR2/4d/-, and MyD88-/- mice as compared to TLR9-/-, TLR4-/- and WT mice
A. Bar diagram demonstrates the percentage severity of each group of mice
(N=16) infected with 5 × 103 pfu HSV-1 RE at day 15 p.i. TLR2-/-,
TLR2/4d-/-, MyD88-/- mice show reduced incidence (HSK score ≥ 3) of
disease as compared to TLR9-/-, TLR4-/-, WT animals.
B. Mean HSK lesion scores at day 8 and day 15 p.i of WT, TLR4-/-, TLR9-/-,
TLR2/4d-/-, TLR2-/- and MyD88-/- mice infected with 5 × 103 pfu
infection dose. ∗∗, (P ≤ 0.001) and ∗, (P ≤ 0.05), statistically significant
differences as compared to WT control.
C. Mean Angiogenesis lesion scores at day 8 and day 15 p.i of WT, TLR4-/-,
TLR9-/-, TLR2/4d-/-, TLR2-/- and MyD88-/- mice infected with 5 × 103
pfu infection dose. ∗∗ (P ≤ 0.001) and ∗ (P ≤ 0.05), statistically significant
differences as compared to WT control animals.
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Figure 3. Compromised inflammatory cell influx into the cornea of TLR2-/- ,
TLR9-/-, TLR2/4d-/- , and MyD88-/- mice as compared to TLR4-/- and WT mice
at 48 h p.i.
Mice were infected with 5 x 103 pfu HSV-1 RE. Mice were terminated at 48 h p.i.,
and eyes were processed for cryo-sections. Hematoxylin and eosin staining was
carried out on 6-µm sections. Dot plots associated with the sections represent the
Gr1+CD11b+ cells in the WT and TLR4-/- corneas (Gr1+ on X-axis and CD11b+
on Y-axis). The numbers in the dot plots denote the percentage of inflammatory
cells expressing both Gr1+ and CD11b+ markers.
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Figure 4. Compromised cell infiltration into the TG of TLR2-/- and MyD88-/mice as compared to TLR4-/- and WT mice
Single-cell suspensions of TG cells were prepared from four TGs at 48 h and 96 h
p.i. for each group of mice. The cells were stained with FITC-labeled anti Gr-1,
CD11c, F4/80 and PE labeled CD11b antibody. The number of positive cells was
determined by FACS. The bars represent the number of cells/ 4×105 cells from the
TG at 48 h and 96 h p.i. ∗, (P ≤ 0.05) and ∗∗, (P ≤ 0.01), statistically significant
difference as compared to WT animals.
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Figure 5. Reduced levels of cytokines and angiogenic factor in the corneas of
TLR2-/- and MyD88-/- mice as compared to TLR4-/- and WT mice.
At the indicated time points, six corneas/group were processed to measure the IL6, IL-1β, MIP-2 and VEGF levels. Levels of IL-6, IL-1β, MIP-2 and VEGF were
estimated from the supernatants of corneal lysates of WT, TLR2-/-, TLR2/4d-/-,
TLR4-/-, TLR9-/- and MyD88-/- animals infected with 5 × 103 pfu HSV-1 RE by
an antibody capture ELISA as outlined in materials and methods. ∗, (P ≤ 0.05) and
∗∗, (P ≤ 0.01), statistically significant difference as compared to WT animals.
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Figure 6. Increased expression of proinflammarory cytokines and reduced levels
of IL-10 in TLR4-/- animals as compared to WT
At the indicated time points, six corneas/group and cervical DLNs from individual
mice (N=4) were processed to measure the IL-10, IL-6, IFN-γ levels of WT and
TLR4-/- animals infected with 5 × 103 pfu HSV-1 RE and cytokines measured by
antibody capture ELISA as outlined in materials and methods. ∗, (P ≤ 0.05),
statistically significant differences as compared to WT animals.
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Figure 7. Reduced expression of COX-2 in TLR2-/- animals as compared to WT
Single-cell suspensions of corneal cells were prepared from two corneas (Number
of mice = 8) at day 3 and day 6 p.i. Intracellular COX-2 staining was carried out as
described in materials and methods. In Fig. 7A and B, bar diagrams demonstrate
the total number of COX-2+ cells and total number of COX-2+Gr1+ cells /1×105
corneal cell respectively. ∗, (P ≤ 0.05), statistically significant differences as
compared to WT animals.
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Table 1
Percentage of mortality in various groups by day 15 p.i.
2 × 104 pfu/eye

5 × 103 pfu/eye

WT

30 %

< 20 %

TLR4-/-

45 %

< 20 %

TLR9-/-

<15 %

-

TLR2-/-

<15 %

-

MyD88-/-

100 %

70 %
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Table 2
a

Virus titer in log10 pfu/ml in TG and brain at different time points p.i.
Day4 p.i.

Day7 p.i.

TG

Brain

WT

3.2 ± 0.04

1.7 ± 0.29

TLR9-/-

3.7 ± 0.08

TLR2-/MyD88-/a

TG
b

Brain

UD

UD

2.3 ± 0.2

UD

UD

3.2 ± 0.03

2.3 ± 0.07

UD

UD

3.7 ± 0.06

2.2 ± 0.20

UD

c

3.8 ± 0.30

Mice were infected with 3 x 105 pfu of HSV-1 RE and killed at day4 or day7

to measure viral titers using a standard plaque assay from brain and TG
homogenates (n = 3).
b

UD, Undetected, i.e., below the sensitivity of the assay (<10 pfu/ml)

c

Virus was also detected in the brain tissues collected from dying MyD88-/-

mice (day-10-15).
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Table 3
a

Virus titer in log10 pfu/ml in the cornea at different time points p.i
Day3 p.i.

a

Day7 p.i.

WT

3.2 ± 0.18

b

TLR4-/-

3.7 ± 0.21

UD

TLR9-/-

3.3 ± 0.17

UD

TLR2-/-

3.1 ± 0.08

UD

MyD88-/-

3.2 ± 0.10

UD

UD

Mice were infected with 3 x 105 pfu of HSV-1 RE. Virus titer was estimated

by standard plaque assay from swabs taken from infected corneas of mice (n =
4) at the indicated time points.
b

UD, Undetected, i.e., below the sensitivity of the assay (<10 pfu/ml).
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Part-III
Enhanced viral immunoinflammatory lesions in
mice lacking IL-23 responses.
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Research described in this chapter is a slightly modified version of an article that
in accepted for publication in Microbes and Infection by Pranita P Sarangi,
Bumseok Kim, Ahmet Kursat Azkur, Shilpa Deshpande Kaistha, and Barry T.
Rouse
*Kim B, *Sarangi PP, Ahmet Kursat Azkur, Deshpande Kaistha S, Rouse BT.
Enhanced viral immunoinflammatory lesions in mice lacking IL-23 responses. Microbes and infections. 2008 (article in Press) * Equal contribution of authors.
Copyright © 2008 Published by Elsevier Masson SAS
In this chapter “our” and “we” refers to me and co-authors. My contribution in the
paper includes (1) Selection of the topic (2) Compiling and interpretation of the
literature (3) Designing experiments (4) understanding the literature and
interpretation of the results (5) providing comprehensible structure to the paper (6)
Preparation of graphs, figures and tables (7) Writing and editing
Abstract
Herpes simplex virus (HSV) infection of the cornea culminates in an
immunopathological lesion (stromal keratitis – SK) that impairs vision. This report
shows that HSV infection results in IL-23 up-regulation, but if this response fails
to occur, as was noted in p19-/- mice, the severity of lesions, their incidence and
the level of viral induced angiogenesis were significantly increased compared to
wild-type (WT) animals (p < 0.05). The higher disease severity in p19-/- mice
appeared to be the consequence of an increased IL-12 response that in turn led to
the induction of higher numbers of IFN-γ producing CD4+ T cells, the principal
orchestrators of SK. Our results indicate that the severity of HSV induced
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immunopathological lesions may be mainly the consequence of IL-12 driven Th1
T cell reactions rather than the action of IL-17 producing cells controlled by IL-23.
Introduction
Ocular

infection

with

herpes

simplex

virus

(HSV)

culminates

in

immunoinflammatory lesions in the stroma (stromal keratitis – SK) that is a
common cause of human blindness [1]. Understanding the pathogenesis of SK is
expected to result in more effective control measures by targeting critical events.
Studies in a mouse model of SK have revealed that many key events are set off by
HSV infection. Among the early events are the production of several cytokines
such as IL-6 and IL-12 [2, 3], chemokines such as MCP-1 and MIP-2 [4, 5] as well
as several molecules that induce neovascularization of the normally avascular
cornea [6]. Past studies by us and others have shown that IL-12 is upregulated by
HSV infection [2, 7] and may be involved in generating IFN-γ producing CD4+ T
cells that are thought to be the main orchestrators of SK lesions [8]. In support of
this, animals unable to generate normal IL-12 responses develop diminished
lesions [2]. Currently, the role of the structurally similar IL-23 molecule in the
pathogenesis of SK is not understood. This topic is of interest since several
autoinflammatory and some anti-microbial inflammatory reactions that were
formerly thought to be mainly IL-12/IFN-γ mediated immunoinflammatory events
were subsequently shown to be more the consequence of responses influenced by
IL-23 that promotes the expansion and survival of pathogenic IL-17 producing T
cells [9-11]. Although T cells that produce IL-17 have been demonstrated in
human SK lesions [12] the respective role of Th1 and Th17 pathogenic T cells as
orchestrators of SK is poorly understood. The present report evaluates the role of
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the IL-23/IL-17 axis in SK by comparing the outcome of infection in wild-type
(WT) to those in mice unable to generate IL-23 because of p19 knockout. Our
results show that HSV infection causes the upregulation of IL-23 but these results
in only minimally detectible CD4/IL-17 producing responses in the eye.
Furthermore lesions were significantly more severe in animals unable to produce
IL-23 making it doubtful if the IL-23/IL-17 axis is mainly responsible for the
ocular inflammatory lesions. In fact, in the absence of p19 more abundant IL-12
and Th1 responses were evident. We presume it is the IFN-γ producing Th1, rather
than Th17 T cells, that are mainly responsible for mediating SK.
Materials and Methods
Mice
Female C57BL/6 mice, 6 to 7 weeks old, were purchased from Harlan SpragueDawley (Indianapolis, IN). P19 deficient mice were kindly provided by Dr. Nico
Ghilardi (Genentech, Inc., CA). All investigations followed guidelines of the
Committee on the Care of Laboratory Animals Resources, Commission of Life
Sciences, National Research Council. The animal facilities of the University of
Tennessee (Knoxville) are fully accredited by the American Association of
Laboratory Animal Care.
Virus
HSV-l strain RE (kindly provided by Dr. Robert Lausch, University of Alabama,
Mobile, AL) was used in all procedures. Virus was grown in Vero cell monolayers
(American Type Culture Collection, Manassas, VA; Cat. no. CCL81), titrated, and
stored in aliquots at -80°C until used.
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Corneal HSV infection
Corneal infections of all mouse groups were conducted under Avertin deep
anesthesia. The mice were scarified lightly on their corneas with a 30-gauge
needle, and a 2 µl drop containing different plaque-forming units (PFU) of HSV-1
RE was applied to the eye and gently massaged with the eyelids.
Real-time quantitative PCR
The total cellular RNA was isolated from corneas and draining lymph nodes
(DLNs) by using an RNeasy protect mini kit (Qiagen, Valencia, CA) according to
the manufacturer’s instruction. All samples were treated with RNase-free DNase
(Qiagen). The extracted RNA was reverse transcribed using oligo (dt) primers and
reverse transcriptase enzyme (Promega, Madison, WI) according to standard
protocol. The cDNA obtained was used as a template for real-time quantitative
PCR and real-time PCR was performed using a QuantiTect SYBR Green PCR kit
(Qiagen).

The

primers

used

were

(TGCTGGATTGCAGAGCAGTAA)

murine
and

p19

forward
reverse

(GCATGCAGAGATTCCGAGAGA). Initially, mRNA levels were normalized to
the GAPDH mRNA level. Briefly, a standard curve was generated using the PCR
product of interested gene cloned into a pCR-XL-TOPO vector (Invitrogen, San
Diego, CA). After spectrophotometric determination of the plasmid DNA
concentration, the copy number was calculated using the following formula: (X
g/µl DNA/ (plasmid length in bp × 660) × 6.022 × 1023 = Y molecules/µl). Test
samples were run in triplicate with a dilution series and the mean value of a
particular dilution was used. Data are expressed as copy number per sample.
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Clinical observations
The eyes were examined on different days after infection for the development of
clinical lesions by slit-lamp biomicroscopy (Kawa Co, Nagoya, Japan), and the
clinical severity of keratitis of individually scored mice was recorded. The scoring
system was as follows: 0, normal cornea; +1, mild corneal haze; +2, moderate
corneal opacity or scarring; +3, severe corneal opacity but iris visible; +4, opaque
cornea and corneal ulcer; +5, corneal rupture and necrotizing stromal keratitis. The
severity of angiogenesis was recorded as described previously [6]. In reference to
the angiogenic scoring system, the method relied on quantifying the degree of
neovessel formation based on three primary parameters: 1) the circumferential
extent of neovessels (as the angiogenic response is not uniformly circumferential in
all cases); 2) the centripetal growth of the longest vessels in each quadrant of the
circle; and 3) the longest neovessel in each quadrant was identified and graded
between 0 (no neovessel) and 4 (neovessel in the corneal center) in increments of
~0.4 mm (radius of the cornea is ~1.5 mm). According to this system, a grade of 4
for a given quadrant of the circle represents a centripetal growth of 1.5 mm toward
the corneal center. The score of the four quadrants of the eye were then summed to
derive the neovessel index (range, 0 to 16) for each eye at a given time point.
Cytokine assay
For cytokine (IFN-γ, IL-12p35, IL-12p40) assay, splenocytes from mice were
suspended in 10% RPMI-1640, and 106 cells in 1 ml were stimulated in vitro with
irradiated syngeneic-enriched naïve splenocytes pulsed with UV-inactivated HSV
(MOI, 1.5 before UV inactivation). Similar number of cells was Con A-stimulated
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(5 μg/106 cells/ml) in 96-well plates. Plates were incubated at 37°C for 72 h. The
supernatant fluid was collected and stored at -80°C until use. These supernatants
were screened for the presence of individual cytokines by enzyme-linked
immunosorbent assay (ELISA).
Flow cytometric analysis
Single-cell suspensions were prepared from the SK corneas or lymphoid organs
(spleen and DLNs). For the preparation of corneal samples, four corneas per group
were dissected, pooled together, and digested with 60 U/ml Liberase (Roche
Diagnostics, Alamenda, CA) for 60 min at 37°C in a humidified atmosphere of 5%
CO2. After incubation, the corneas were disrupted by grinding with a syringe
plunger on a mesh and a single-cell suspension was made in complete RPMI 1640
medium. Next, the single-cell suspensions obtained from corneal or lymphoid
samples were stained for FACS. Briefly, single cells were first blocked with an
unconjugated anti-CD32/CD16 mAb (BD Biosciences, San Jose, CA) for 15 min
at 4°C in FACS buffer and stained by anti-CD4-APC, anti-CD8-PerCp, CD11cPerCp, or CD11b-APC antibody (BD Biosciences) for 30 min. Cells were fixed
and permeabilizied using Cytofix/Cytoperm (BD Biosciences) solution for
approximately 30 minutes, followed by washing with perm washing solution.
Intracellular staining was done with anti-IFN-γ-PE, anti-IL-12-PE, or anti-IL-17PE antibody (BD Biosciences) for 30 minutes on ice and washed twice with perm
wash. Finally, the cells were washed with FACS buffer and samples were acquired
on a FACScan (BD Biosciences). The data were analyzed using the CellQuest 3.1
software (BD Biosciences).
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Protein quantification of corneal or lymphoid organs lysates by ELISA
The lysates from HSV infected cornea or lymphoid organs (spleen and DLNs)
were used for the measurement of IFN-γ, IL-12, IL-23, or TGF-β by a standard
sandwich ELISA protocol. For preparation of sample lysates, four corneas or
lymphoid organs/time point (n = 4) were collected and minced with liquid
nitrogen. Minced pieces were collected in 1 ml of DMEM without FCS and
homogenized using an ultra sonicater (Heat systems-Ultrasonics, NY). The lysates
were then clarified by centrifugation at 12,000 rpm for 5 min at 4°C. The
supernatant was collected and stored at –80°C till further use. The ELISA plate
was coated with anti-mouse capture antibody (100 μl/well of the capture antibody
at various concentrations, BD Biosciences) and incubated at 4°C overnight. The
plate was washed with 0.05% tween20/PBS and blocked with 3% BSA for 2 h at
37°C. After washing, serially diluted lysates were added to the plate and incubated
at 4°C overnight. The plate was washed and then incubated with biotinylated
detection antibody (BD Biosciences) for 2 h. Finally, peroxidase-conjugated
streptavidin (Jackson ImmunoResearch Laboratory, PA) was added. The color
reaction was developed using ABTS (Sigma-Aldrich, St. Louis, MO) and
measured with an ELISA reader (Spectramax 340; Molecular Devices, Sunnyvale,
CA) at 405 nm. Quantification was performed with Spectramax ELISA reader
software version 1.2.
Virus recovery and titration
Swabs of the corneal surface were collected at various time points post infection
(p.i.). The swabs were put into sterile tubes containing 600 μl serum free DMEM
with 10 international units (IU) penicillin/ml and 100 µg streptomycin (Life
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Technologies, Grand Island, NY)/ml and were stored at -80°C. For detection and
quantification of virus, the samples were thawed and vortexed. Individual
subsamples (200 μl each sample) were diluted further, and viral titers were
determined by a plaque assay performed on Vero cells as described elsewhere [13].
Statistical analysis
Significant differences between groups were evaluated by using the Student’s t
test. P < 0.05 was regarded as a significant difference between two groups. Results
are expressed as mean ± standard error.
Results
Expression of IL-23 after HSV-1 infection
WT C57BL/6 mice were infected with HSV-1 (5 × 105 PFU) and at various times
p.i. were killed to determine the levels of p19 mRNA by quantitative real-time
PCR in both corneal and DLNs RNA samples. As is shown in Fig.1A, minimal or
undetectable mRNA levels of p19 were present in naïve corneas or lymph nodes,
but by day 2 p.i. abundant levels of IL-23 mRNA were detected. In other
experiments, IL-23 protein levels were quantified in corneal extracts as well as
extracts of lymphoid organs by ELISA in animals infected with different doses of
virus (5 × 103, 5 × 104, 5 × 105 PFU). Peak levels were found with the highest dose
used for infection (Fig. 1B). These results indicate that IL-23 is up-regulated by
HSV infection and could perhaps participate in the immunopathogenesis of
herpetic SK.
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The absence of IL-23 production results in more severe disease
The expression of disease was compared in WT and p19-/- mice at various times
p.i. upon infection with different doses of virus (5 × 103, 5 × 104, 5 × 105 PFU). At
high doses of virus used for infection (5 × 104 and 5 × 105 PFU) disease severity in
both WT and p19-/- animals was of similar magnitude (Fig. 2A). However, at a
low dose of infection (5 × 103 PFU) highly significant differences were observed
in the susceptibility of WT and p19-/- animals. In the latter, more eyes developed
lesions and the mean severity scores of both angiogenesis and SK lesions were
significantly more severe than in WT animals (P < 0.05, Fig. 2B). Lesions also
occurred slightly earlier in p19-/- animals. Overall an average result of three
separate experiments reveal that 80% of p19-/- developed SK of 3 or greater where
as only 33% of WT animals developed such severity (Fig. 2C). Thus the failure to
generate an IL-23 response results in more severe lesions at least at minimal doses
of infection.
As the presence of replicating virus may contribute to lesion severity, we
compared the levels of virus in the eye swabs collected from both groups of
animals at different time points. As is evident in Fig. 2D, virus clearance occurred
earlier in the corneas of p19-/- as compared to WT animals (p < 0.05). Thus
although lesions were more severe in p19-/- animals virus was cleared from the
epithelium earlier than in WT.
P19-/- animals develop more severe Th1 immune response
In an attempt to explain why p19-/- mice showed more severe responses than WT
animals, we infected both groups with the low dose of virus (5 × 103 PFU) and
lymphoid samples were collected at day 20 post infection to compare the
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magnitude of the HSV specific T cell responses. This was done by stimulating T
cells with antigen and comparing the induced cytokine response by ELISA. As
shown in Fig. 3A, splenocytes from p19-/- mice produced significantly higher (p <
0.05) levels of IFN-γ as compared to WT controls. Similarly, although no
difference was observed in the production of p40 subunit, the IL-12p35 level was
significantly higher in p19-/- as compared to WT (p < 0.05). These results may
mean that in the absence of p19 the Th1 type of immune response is increased.
To determine which cell populations contribute to the Th1 type immune
response against HSV, isolated splenocytes from both groups having SK lesions
were stimulated with anti-CD3 and anti-CD28 to analyze cytokine production. As
assessed by intracellular cytokine staining assay, the percentage and absolute
number of IFN-γ expressing CD4+ T cells as well as IFN-γ expressing CD8+ T
cells was significantly higher (p < 0.05) in p19-/- mice as compared to WT control
animals (Fig. 3B). Similar results were also obtained when cells were stimulated
with syngeneic naive splenocytes pulsed with HSV (Fig. 3C). In addition, we also
compared the numbers of IL-12 producing cells in the infected DLNs and spleen
in the two groups of animals. As shown in Fig. 4A, higher numbers of IL-12
expressing cells were noted in the p19-/- animals as compared to WT. The
majority of cells producing IL-12 were found to be CD11c+ CD11b- (Fig. 4B).
Total cell numbers in the DLNs and spleen of p19-/- were marginally increased as
compared to WT animals (not shown) indicating that relative population of IFN-γ
or IL-12 expressing cell types were greater in lymphoid organs of p19-/- animals.
Thus these data indicate that p19-/- mice generated a greater Th1 type of immune
response than did WT animals.
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The nature of the response in p19-/- and WT corneas was also measured
using corneas isolated from the infected animals of both the groups. As shown in
the Fig. 5A, the protein levels of IFN-γ and IL-12 were significantly higher in the
lysates of p19-/- corneas as compared to WT at day 20 p.i. (p < 0.01). We next
determined the number of IFN-γ expressing cells in the collagenase digested
corneas of each group. As shown in Fig 5B, there was approximately two and four
fold increase in the total number of IFN-γ producing cells in the p19-/- corneas
after anti-CD3 and CD28 stimulation at day 10 and day 20 respectively as
compared to WT. Such IFN-γ producing cell types in SK corneas were mainly
CD4+ T cells confirming that pathogenesis of herpetic SK is contributed by Th1
type CD4+ T cells (Fig. 5C). Similarly, the numbers of IL-12 producing cells were
also higher in p19-/- corneas as compared to WT controls (Fig. 5B). Total cell
numbers in the SK cornea of p19-/- mice were also greater than those of WT mice
at day 10 and 20 p.i. (Fig. 5D) suggesting both absolute numbers and frequencies
of such cells in the corneas of p19-/- animals were higher as compared to WT
animals. These data indicate that the p19-/- mice generated a more abundant Th1
type of immune response in the corneas than WT.
P19-/- mice develop less Th17 immune response
Previous studies showed that IL-23 expands a pathogenic CD4+ T cell population
that produces IL-17 and contributes to inflammation [9]. To record such an effect,
isolated splenocytes, DLN cells, and corneal cells from both groups having SK
lesions were stimulated with anti-CD3 and anti-CD28 to analyze IL-17 production.
As assessed by intracellular cytokine staining assay, comparable and little levels of
IL-17-producing CD4+ T cells were observed in the spleen, DLNs, and corneas of
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both p19-/- and WT mice at day 10 post infection (data not shown). At day 20 post
infection, however, higher levels of IL-17-producing CD4+ T cells were observed
in the SK cornea, spleen, and DLNs of WT compared to p19-/- mice (Fig. 6A).
Since TGF-β is critical for the induction of Th17 cells [14], we measured the
protein levels of TGF-β in the corneas and lymphoid tissues of p19-/- and WT
animals. We could not find significant differences in the TGF-β levels in the
naïve and infected p19-/- animals corneas as compared to WT. Interestingly,
significantly higher levels of TGF-β was found in the cervical DLNs but not the
spleens of p19-/- animals at 5 days p.i. (Fig. 6B). These data indicate that IL-23 is
needed for the maintenance of the Th17 cells post infection.
Discussion
In many immunoinflammatory lesion events thought formerly to represent
the consequences of IL-12 controlled IFN-γ producing Th1 type T effector cells
were subsequently shown to be more the consequence of pathologic CD4+ T cells
that produce IL-17 [11]. The differentiation and expansion of the latter was
influenced by IL-23 rather than IL-12. We, and others, had shown the relevance
and importance of IL-12 and IFN-γ producing CD4+ T cells in the orchestration of
HSV induced inflammatory reactions in the cornea [1, 2, 8, 15, 16], but any role
for Th17 mediated events had not been studied. The present investigation shows
that ocular infection does result in IL-23 induction but the extent of the ocular
Th17 response in the cornea was very limited. Furthermore, we observed that the
severity of HSV induced SK lesions were in fact more severe than in WT animals
if mice were unable to generate IL-23 because of p19 knockout. Thus in this viralinduced immunopathological reaction, SK lesions would appear to be mainly
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orchestrated by Th1 cells as advocated by several groups prior to our knowledge
about the existence of the IL-23/IL-17 axis of inflammatory disease mediation.
The evidence that the IL-12/IFN-γ and IL-23/IL-17 represent separate
mechanisms of cell mediated tissue damage appears now to be well accepted [9,
11, 17, 18]. In fact, based on the use of knockout animals, as well as approaches
using in vivo cytokine neutralizing antibodies, the trend has usually been to show
that lesions assumed to represent the consequence of IL-12/ IFN-γ mediated events
in fact primarily involved IL-23/IL-17 mediated mechanisms. This has been
shown true for several autoimmunities and some inflammatory reactions against
microbes [10, 11, 17]. Reasons why one type of inflammatory reaction prevails
over another are usually not available. However, with some microbes and some
purified microbial products more effective induction of IL-23 compared to IL-12
has been show to occur. This happens with Bordetella pertussis [19] as well as
with stimulation by peptidoglycan from Staphylococcus aureus [20]. In addition,
various toll-like receptor (TLR) ligands were shown to differentially stimulate IL12 and IL-23 production from dendritic cells (DCs) [21, 22]. HSV has been shown
to possess both TLR2 and 9 ligand activity [23] and in addition causes the release
of endogenous TLR ligands such as hsp70 from infected cells [24, 25]. One or
more of these TLR ligands could stimulate IL-12 and IL-23 production
differentially in SK corneas. We are currently attempting to compare the relative
IL-12/IL-23 inducing capacity of HSV, infected cell extracts and known TLR
ligands in various cell types derived from the eye. We anticipate that HSV may be
a better inducer of IL-12 than IL-23 and that the resultant IFN-γ response from
innate cells, that includes neutrophils [26], may serve to suppress any concomitant
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Th17 responses. Such suppression of Th17 responses by IFN-γ has been shown to
occur in vitro [27]. Moreover, HSV may also be a weak inducer of TGF-β which
appears to act as a cofactor for Th17 development [28]. In our current study, there
was no significant increase in the TGF-β levels in the WT corneas post infection.
Additionally, we did not find any significant difference in the levels of TGF-β in
the corneas of p19-/- animals as compared to WT animals. Taken together these
events may explain the minimal Th17 response in the eye during HSV induced
immunopathology, and such ideas are being further investigated.
Arguing forcefully against a major role for IL-23/Th17 induced tissue
damage in the SK system was the observation that without the ability to produce
IL-23 because of p19-/-, lesions were more severe than in WT. In preliminary
results, we have also confirmed the previous observation of the Ghiasi group [2]
that corneal scarring becomes less severe in animals unable to make IL-12 because
of p35-/-. Moreover, animals unable to respond to IL-12 because of STAT4
knockout develop only mild lesions of SK [29]. The reasons for the enhanced
pathology in p19-/- animals appeared to be associated with the increased IL-12/
IFN-γ response that occurred in such animals. These enhanced responses were
noted both in the spleen as well as in ocular inflammatory sites. The better IFN-γproducing CD4+ T cell response likely accounted for the more severe SK lesions in
p19-/- animals. Presumably in the absence of p19 more of the available p40
subunit may be able to dimerize with p35 subunit leading to more IL-12
production. Such a finding was also suggested to the observation of Becker et al
[22] in an experimental colitis model wherein p19-/- animals were shown to
develop more severe colitis than the intact animals. They also observed elevated
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levels of IL-12 production and the reversal of the phenotype by administration of
blocking antibody to the p40 subunit.
In our model, p19-/- animals also cleared the infecting virus more promptly
presumably because of the enhanced production of IFN-γ in p19-/- compared to
WT animals. Furthermore, greater numbers of CD11c+CD11b+ cells as well as
CD11c+CD11b- cells were also observed in the ocular tissues of p19-/- animals
compared to WT (data not shown). Such cells may be myeloid and plasmacytoid
DCs respectively, an abundant source of IFN-α which also might explain the more
rapid clearance of virus from the eyes of p19-/- animals [30].
In summary, our results make the case that SK remains a disease whose
mechanism of tissue damage appears to be mainly the consequence of an IL-12
influenced Th1 IFN-γ producing type of T cell rather than by a pathogenic Th17
producing mechanism. The latter likely plays only a minor role but this might
synergize with the Th1 pathogenic response as has been suggested to occur in
EAE model [31]. We are currently attempting to confirm our observations using
adoptive T cell transfer approaches with in vitro generated Th1 and Th17 specific
cells along with evaluating the effects of inhibition studies with specific anti-sera.
Understanding the mechanisms is considered important as it could impact on
measures used to control this important tissue damaging disease process.
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Figure 1. Expression of IL-23p19 mRNA and protein in the corneas and
lymphoid organs after HSV-1 ocular infection
(A) WT mice were infected with 5 × 105 PFU of HSV-1 on their scarified corneas.
At different time points, mRNA was extracted from the corneas and DLNs, and
reverse transcribed into cDNA. Kinetic expression of IL-23p19 mRNA was
measured by real-time PCR. Test samples were run in triplicate with a dilution
series and the mean value of a particular dilution was used. Data are expressed as
copy number per sample. (B) WT mice (n = 3) were ocularly infected with
different doses of virus (5 × 105, 5 × 104, 5 × 105 PFU) and levels of IL-23 protein
were estimated from lysate supernatants of corneas, DLNs, or spleen of mice by an
antibody capture ELISA as described by materials and methods.
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Figure 2. IL-23p19-/- mice have higher SK lesion severity, incidence, ocular
angiogenesis, and enhanced viral clearance
Corneas of IL-23p19-/- and WT mice (n = 4) were infected with various doses of
HSV-1 (5 × 103, 5 × 104, 5 × 105 PFU), and the levels of SK severity and
neovascularization were measured in the corneas by biomicroscopy in groups of
p19-/- (•) and WT (ο) mice. (A) SK lesion severity and angiogenesis scoring was
conducted on day 18 p.i.. Results are representative of one of three independent
experiments. Statistically significant differences in SK and angiogenic score were
observed between the groups (** p < 0.01). (B) Stromal lesion severity and
angiogenesis in IL-23p19-/- and WT mice (n = 4) infected with low dose of HSV1 (5 × 103 PFU) were measured at different time intervals. Results are
representative of three independent experiments. Statistically significant
differences in SK and angiogenic score were observed between the groups (* p <
0.05, ** p < 0.01). Images were taken by stereomicroscopic imaging system at day
19 after virus infection (original magnification, × 40). (C) The incidence of clinical
SK lesions was considered as over score 2 at day 14 p.i.. (D) Infectious virus titers
were compared in the different mice groups (n = 4) following virus infection with
5 × 103 PFU. At days 4 and 6 p.i., swabs of the corneal surface were collected and
were put into serum free DMEM with antibiotics. Individual samples were diluted
further, and viral titers were determined by a plaque assay performed on Vero cells
as described materials and methods. Statistically significant differences in number
of virus on the cornea (* p < 0.05) were observed between the groups.
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Figure 3. Increased Th1 type immune responses in the spleen of IL-23p19-/mice after HSV-1 infection
(A) At day 20 p.i. (5 × 103 PFU/eye), spleen cells of the different mice groups
were used in antigen specific ELISA. For cytokine ELISA assay, splenocytes from
mice were sampled, suspended, and stimulated with irradiated syngeneic-enriched
naïve splenocytes pulsed with UV-inactivated HSV (MOI, 1.5) at 37°C for 72 h.
Levels of individual cytokines were estimated from supernatant fluid by an
antibody capture ELISA as outlined in materials and methods. Statistically
significant differences in levels of individual cytokines (* p < 0.05, ** p < 0.01)
were observed between the groups. At day 10 and 20 p.i., splenocytes of the
different mice groups (n = 4) were used in intracellular cytokine staining assay.
For intracellular cytokine staining assay, isolated spleen cells from both groups
having SK lesions were stimulated with anti-CD3 and anti-CD28 (B) or stimulated
with syngeneic naïve splenocytes pulsed with HSV (C) for 16 h. Single cells were
extracellularly stained with anti-mouse CD4 (APC) and CD8 (PerCp) antibody and
then intracellularly stained with anti-mouse IFN-γ PE antibody. Values shown in
each graph reflect the percentage or number of spleen cells expressing IFN-γ.
Statistically significant differences were observed between the groups (* p < 0.05,
** p < 0.01). Results are representative of two independent experiments.
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Figure 4. Increased population and number of IL-12 expressing cells in the
lymphoid organs of p19-/- mice after HSV-1 infection
At day 10 and 20 p.i., splenocytes or DLNs cells of the different mice groups (n =
4) were used in intracellular cytokine staining assay. Isolated splenocytes or DLNs
cells from both groups having SK lesions were stimulated with anti-CD3 and antiCD28 for 16 h. Single cells were extracellularly stained with anti-mouse CD11b
(APC) and CD11c (PerCp) antibody and then intracellularly stained with antimouse IL-12 PE antibody (A and B). Values shown in each graph reflect the
percentage or absolute number of spleen cells expressing IL-12. At day 10 and 20
p.i., total numbers of splenocytes and DLNs cells of the different mice groups (n =
6) were measured (C).
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Figure 5. Increased Th1 type immune responses in the SK corneas of p19-/mice
3

At day 20 p.i., 6 corneas/group that were infected with 5 × 10 PFU HSV-1 were
processed to measure the IFN-γ or IL-12 cytokine levels (A). Levels of individual
cytokines were estimated from supernatants of corneal lysates of mice by an
antibody capture ELISA as outlined in materials and methods. Statistically
significant differences in levels of cytokines (** p < 0.01) were observed between
the groups. Alternatively, isolated corneal cells from both groups having SK
lesions (10 and 20 post infection) were stimulated with anti-CD3 and anti-CD28
for 16 h. Single cells were extracellularly stained with anti-mouse CD4 APC
antibody and then intracellularly stained with anti-mouse IFN-γ or IL-12 PE
antibody (B and C). Cells were gated on lymphocytes and values shown in each
plot represent the percentage of CD4+ T cells expressing IFN-γ (C). At day 10 and
20 p.i., total cell numbers of collagenase digested cornea of the different mice
groups (n = 6) were measured (D). Statistically significant differences in the
absolute cell numbers of SK cornea (* p < 0.05, ** p < 0.01) were observed
between the groups.
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Figure 6. Decreased Th17 immune response in p19-/- mice after HSV-1
infection
At day 20 p.i., splenocytes, DLN cells, and corneal cells from WT and p19-/- mice
having SK lesions were stimulated with anti-CD3 and anti-CD28 for 16 h. Single
cells were extracellularly stained with anti-mouse CD4 APC antibody and then
intracellularly stained with anti-mouse IL-17 PE antibody. Cells were gated on
lymphocytes and values shown in each plot represent the percentage of cells
expressing IL-17 (A). Data are representative of two similar experiments. At day 5
3

and 9 p.i., DLNs, spleen, and 6 corneas/group that were infected with 5 × 10 PFU
HSV-1 were processed to measure the TGF-β cytokine levels (B). Levels of TGFβ were estimated from supernatants of each tissue’s lysates of mice by an antibody
capture ELISA as outlined in materials and methods.
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Part-IV
IL-10 and natural regulatory T cells: Two
independent anti inflammatory mechanisms in
HSV induced ocular immunopathology
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Research described in this chapter is a slightly modified version of an article that
in accepted for publication in Journal of Imunology by Pranita P Sarangi, Sharvan
Sehrawat, Susmit Suvas, and Barry T. Rouse
Sarangi PP, Sehrawat S, Suvas S and Rouse BT. IL-10 and natural regulatory T
cells: Two independent anti inflammatory mechanisms in HSV induced ocular
immunopathology. (Journal of Immunology-Accepted)
In this chapter “our” and “we” refers to me and co-authors. My contribution in the
paper includes (1) Selection of the topic (2) Compiling and interpretation of the
literature (3) Designing experiments (4) understanding the literature and
interpretation of the results (5) providing comprehensible structure to the paper (6)
Preparation of graphs, figures and tables (7) Writing and editing
Abstract
Two prominent anti-inflammatory mechanisms involved in controlling HSV-1
induced corneal immunopathology (Stromal Keratitis-SK) are the production of
the cytokine IL-10 and the activity of natural regulatory T cells (nTregs). It is not
known whether under in vivo conditions, IL-10 and nTregs influence the corneal
pathology independently or in concert. In the current study using wild-type (WT)
and IL-10-/- animals, we have assessed the activity of nTregs in the absence of IL10 both under in vitro and in vivo conditions. The IL-10-/- animals depleted of
nTregs prior to ocular infection showed more severe SK lesions as compared to
the undepleted IL-10-/- animals. In addition, nTregs purified from naïve WT and
IL-10-/- animals were equally able to suppress the proliferation and the cytokine
production from anti-CD3 stimulated CD4+CD25- T cells in vitro. Furthermore,
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intracellular cytokine staining results indicated that non regulatory cells expressing
B220 and CD25 markers were the major IL-10 producing cell types in the
lymphoid tissues of HSV infected mice. In contrast, in the infected corneas, cells
with the CD11b+Gr1+ phenotype along with a minor population of Foxp3-CD4+
and a few F4/80+ cells produced IL-10. Our current investigations indicate that at
least two independent anti-inflammatory mechanisms are involved in limiting the
corneal lesions in SK, both of which may need to be modulated to control SK
therapeutically.
Introduction
Ocular infection with herpes simplex virus (HSV) results in a chronic
immunoinflammatory reaction in the cornea that can result in blindness. Studies in
animal models of stromal keratitis (SK) have revealed that the infection, possibly
in part because of its TLR ligand activity sets off a range of critical cellular and
molecular events [1], but the actual SK lesions appear to be orchestrated mainly by
CD4+ T cells that are primarily type 1 cytokine producers [2, 3]. SK lesions may
resolve spontaneously and when this occurs in the mouse model, it may be
associated with the up regulation of IL-10 production [4]. Additionally, the
severity of SK may also be affected by the activity of Foxp3+ regulatory T cells
[5]. Accordingly, the depletion of such cells may result in more severe lesions [5]
and recently we have shown that the adoptive transfer of in vitro generated Foxp3+
Tregs may modulate the severity of SK lesions [6].
One potential mechanism by which the Tregs carry out their regulatory
effects is by the production of inhibitory cytokines such as IL-10 and TGF-β [7].
In fact some types of Tregs may be induced by IL-10 and mediate regulation
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principally by producing IL-10 [8]. In some infectious disease models, these
inducible Tregs (sometimes referred to as Tr1 cells) are considered to play a
pivotal role in viral pathogenesis [9]. That IL-10 is critical for resolution of
inflammatory lesions has been shown in many systems including SK [10]. Thus
SK lesions may be more severe in IL-10-/- animals [11] but it is unclear if this
reflects the failed function of some type of regulatory T cell or be the consequence
of failure of IL-10 production by some innate inflammatory cell type. Thus
macrophages and some dendritic cells (DCs) subtypes as well as highly activated
CD4+ T cells may be major sources of IL-10 production [12, 13] and certain
pathogens may encode ligands that can stimulate IL-10 production from some
cells [14, 15].
In the present study, we have compared the pathogenesis of SK in wildtype (WT) and IL-10-/- mice in an attempt to further define if Treg mediated
control of the inflammatory reaction is dependent or independent of IL-10
production. Our results show that compared to WT controls increased SK lesions
occur in the absence IL-10 as well as if nTregs are deleted. Interestingly, depletion
of nTregs even in IL-10-/- animals resulted in even more enhanced SK lesion
severity compared to IL-10-/- mice indicating that the effect of Tregs mainly
occurred independently of IL-10 production. In support of this finding, Tregs
purified from IL-10-/- and WT appeared equally active at suppression and could
inhibit the cytokine production from TCR stimulated CD4+CD25- T cells isolated
from naive and infected WT animals. Furthermore, in the infected corneas, non
regulatory cells with the CD11b+Gr1+ phenotype along with a minor population of
Foxp3-CD4+ and a few F4/80+ cells produced IL-10. Our results show that at least
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two independent anti-inflammatory mechanisms namely, IL-10 and nTregs are
involved in controlling corneal immunopathology in SK. We discuss the
implication of our studies for future novel therapies for SK
Material and methods
Animals
IL-10-/- breeders were obtained from the Jackson laboratory (Bar Harbor, ME) and
were maintained in the animal facility of University of Tennessee. C57BL/6 mice
were obtained from Harlan Sprague-Dawley, (Indianapolis IN). Foxp3-GFP mice
[16] were kind gift from Dr.Mohammed Oukka (Harvard Medical School). To
prevent bacterial superinfection, all mice received prophylactic treatment with
Sulfamethoxazole/Trimethoprim (Biocraft, Elmond Park, NY) at the rate of 5
ml/200 ml drinking water after virus infection. All experimental procedures
followed the guidelines the Association for Research in Vision and
Ophthalmology resolution on the use of animals in research. The animal facilities
of the University of Tennessee (Knoxville) are fully accredited by the American
Association of Laboratory Animal Care.
In vivo depletion of nTregs and HSV-1 infection
IL-10-/- and C57Bl/6 animals were given 0.7mg of anti-CD25 monoclonal
antibody pc61 mAb (Bioexpress) i/p, 3 days prior to corneal infection. Depletion
was tested by staining for CD4+CD25+ cells in the spleen and lymph nodes (Fig.
1A). More than 80% depletion was achieved by day 3 after depletion. HSV-1
strain RE (obtained from R. Lausch, University of South Alabama College of
Medicine) was used in all procedures. Virus was propagated and stored as
described previously [17]. For all experiments 6-8 week old females were used
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except for comparison of IL-10-/- with Treg depleted IL-10 animals in which 9-10
week old male mice were used. Corneal infections of all mouse groups were
conducted under deep anesthesia induced by intra-peritoneal injection of Avertin
(Sigma-Aldrich.St.Louis, MO). The mice were scarified on their corneas with a 27
gauge needle and infected with a 3 μl drop containing 5 × 105 plaque-forming units
(PFU) of HSV-1 was applied to the eye and gently massaged with the eyelids.
Clinical observation
The eyes were examined on different days post infection (p.i.) for the development
of clinical lesions by slit-lamp biomicroscopy (Kawa Co., Nagoya, Japan), and the
clinical severity of keratitis lesions and development of neovascularization of
individually scored mice was recorded as described previously [18]. In brief, the
scoring system was as follows: 0, normal cornea; +1, mild corneal haze; +2,
moderate corneal opacity or scarring; +3, severe corneal opacity but iris visible;
+4, opaque cornea and corneal ulcer; +5, corneal rupture and necrotizing stromal
keratitis. Similarly, the angiogenic scoring system relied on quantifying the degree
of neovessel formation based on three primary parameters: 1) the circumferential
extent of neovessels (as the angiogenic response is not uniformly circumferential in
all cases); 2) the centripetal growth of the longest vessels in each quadrant of the
circle; and 3) the longest neovessel in each quadrant was identified and graded
between 0 (no neovessel) and 4 (neovessel in the corneal center) in increments of
~0.4 mm (radius of the cornea is ~1.5 mm). According to this system, a grade of 4
for a given quadrant of the circle represents a centripetal growth of 1.5 mm toward
the corneal center. The score of the four quadrants of the eye were then summed to
derive the neovessel index (range, 0 to 16) for each eye at a given time point.
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Histopathology
For histopathologic analysis, eyes from different groups of mice were extirpated at
the indicated time point p.i. and snap-frozen in OCT compound (Miles, Elkart,
IN). Six micron thick sections were cut, air dried in a desiccation box, and stained
with hematoxylin and eosin (Richard Allen Scientific, Kalamazoo, MI).
Flow cytometry
For flow cytometry measurement of the infiltrating cells, four corneas per time
point per group were collected at indicated time points by dissecting the corneal
buttons above the limbus by a scalpel. Similarly, two trigeminal ganglias (TGs)
were collected per time point. Corneas or TGs were digested in Liberase (Roche
Diagnostics Co., Indianapolis, IN) for 45 min at 37oC. Cervical draining lymph
nodes (DLNs) and spleens were also collected from individual animals. Single cell
suspension was prepared as described elsewhere [19]. The Fc receptors were
blocked with unconjugated anti-CD16/32 (BD Pharmingen, San Diego, CA) for 30
min. Samples were incubated with fluorescein isothiocyanate (FITC) labeled antiGr-1, anti-CD11b, anti-CD11c, anti-NK1.1, anti- B220, anti-CD19, anti-CD25
(7D4), anti-CD8 (BD Pharmingen), anti-F4/80 (eBioscience), and PerCpCy5.5
labeled anti-CD4 (BD Pharmingen), antibody for 30 min. For intracellular
cytokine staining PE labeled anti-IL-10, anti-IL-17, anti-IFN- γ and FITC labeled
anti- IFN-γ, anti-TNF-α, antibodies were used (BD Pharmingen, San Diego, CA).
For Foxp3+IL-10+ cell staining, mice expressing Foxp3-GFP were used and
GFP+IL-10+ cells were measured in such mice by using intracellular IL-10
staining. Intracellular staining for IL-10, TNF-α and IFN-γ was performed using
Fixation/Permeabilization Solution Kit with BD GolgiPlug (BD Bioscience). For
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intracellular cytokine staining cells were stimulated with anti-CD3 and anti-CD28
(1μg/ml) or PMA/Ionomycin or UV inactivated HSV (3MOI). Foxp3 staining was
performed using mouse regulatory T cell staining kit (eBiosciences). All samples
were collected on a FACScan (BD Biosciences, San Diego, CA), and data were
analyzed by using cell Quest 3.1 software (BD Biosciences).
Virus specific CD8+IFN-γ+ staining
To determine the number of IFN-γ producing CD8+ T cells in the infected draining
lymph node (DLN) and spleen, intracellular cytokine staining was performed as
previously described [20]. Single-cell suspension of infected DLN and spleen was
prepared. 106 cells/well were cultured in 96-well U bottom plates. Cells were left
untreated or stimulated with SSIEFARL peptide (HSVgB498-505 [synthesized at
Genemed Synthesis, Inc., CA]) (1 μg/ml) for 5 h at 37oC in 5% CO2. Brefeldin A
(10 μg/ml) was added to the culture for the intracellular cytokine accumulation.
Cell surface marker and intracellular cytokine staining for IFN-γ was performed
using a Cytofix/Cytosperm kit (BD Pharmingen). All samples were collected with
a FACScan and were analyzed with Cell Quest 3.1 software.
Purification of CD4+CD25+ and CD4+D25- T cells
CD4+CD25+ and CD4+D25- Tregs were purified from the lymph nodes of WT and
IL-10-/- mice using a Treg isolation kit (Miltenyi Biotec, CA) according to the
suggested protocol. The purity of cells ranged from 89–92% (Fig. 8A). Accessory
cells were isolated from spleens of WT mice by depleting Thy1.2+ cells using
Thy1.2 magnetic beads (Miltenyi Biotec, CA). Thy1.2 depleted cells were
irradiated before adding to the cultures. CD4+D25- T cells from Thy1.1 B6 animals
were used for in vitro cultures.
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Cytokine inhibition and in vitro suppression Assay
Purified Tregs (5×105/well) from IL-10-/- and WT animals were cultured with
CD4+CD25- T cells (5×105/well) isolated from naïve and infected WT animals
along with irradiated splenocytes (1×106/well). Anti-CD3 antibody was added to
the wells (1μg/ml) .Cells were cultured in a 48 well plate and the culture
supernatants were collected after 48 h and the levels of IFN-γ and IL-2 measured
by sandwich ELISA. For in vitro suppression assays, in one of the experiment
CD4+CD25- T cells from Thy1.1 mice (1×105/well) were labeled with CFSE (0.5
μM) and were cultured in a 96 well plate with different dilutions of WT or IL10-/CD4+CD25+ T cells (1:1, 1:2, 1:4, 1:8, 1:16, 1:32) in the presence of anti-CD3
antibody (1μg/ml) and antigen presenting cells (APCs) (2×105/well).
Cytokine ELISA
Cervical DLNs from individual mice and six corneas per group were collected at
the indicated time points. The DLNs and corneas were sonicated and the level of
IL-6, IL-12 and IL-10 were measured in the supernatants. Similarly, culture
supernatant from the in vitro suppression assay was collected and the level of IL-2
and IFN-γ were determined by a standard sandwich ELISA protocol. Anti IL-6,
IL-12, IL-2, IL-10 and IFN-γ capture and detection antibodies were purchased
from BD Pharmingen and standard recombinant murine IL-6, IL-12. IL-2, IL-10
and IFN-γ were obtained from R&D Systems (Minneapolis, MN). Biotinylated
detection antibodies were purchased from BD Pharmingen. The color reaction was
developed using ABTS (Sigma-Aldrich, St. Louis, MO) and measured with an
ELISA reader (Spectramax 340; Molecular Devices, Sunnyvale, CA) at 405 nm.
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Quantification was performed with Spectramax ELISA reader software version
1.2.
Statistical Analysis
Statistical significance was determined by Student's t test. P < 0.05 was regarded
as a significant difference between the groups.
Results
The absence of IL-10 and depletion of nTreg results in increased SK severity
The outcome of HSV infection was followed and compared in three groups of
mice that were age and sex matched and ocularly infected with the same dose of
HSV-1 RE. The pattern of disease that developed differed significantly in the three
groups. Thus both IL-10-/- and Treg depleted animals showed heightened
susceptibility compared to WT animals (Fig.1B and C). Clinical lesions were
evident in IL-10-/- animals before those in other groups. At 8 days p.i., the
incidence of SK (lesion score ≥3) was 0 and 30% in WT and IL-10-/- animals
respectively (not shown). The majority of IL-10-/- animals had developed
moderately severe lesions (≥3) by 16 day p.i. (90% in the experiment shown in
Fig. 1B). In contrast, less than 40% of WT animals in the same experiment
developed ≥ 3 lesions and almost two fold more than WT in the nTreg depleted
group (Fig. 1B). The pattern of more severe responses in IL-10-/- and Treg
depleted animals was also evident when the extent of angiogenesis was quantified
in the different groups (Fig.1E and F). Eyes showing median responses in each
group were selected for histological analysis. As is evident in Fig. 2A,
inflammatory reactions were more severe than in WT in both the IL-10-/- and Treg
depleted animals. In other experiments, corneal samples were collected from 8
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randomly selected eyes taken from animals at 17 days p.i. to prepare single cell
suspensions following collagen digestion for phenotypic analysis by flow
cytometry. Firstly, total viable cell numbers recovered from IL-10-/- and Treg
depleted animals was greater than WT animals (Fig.2C). In addition, the frequency
of cells with the neutrophil phenotype was also higher in IL-10-/- and nTreg
depleted WT as compared to WT animals (Gr1+CD11b+ cells, Fig. 2B). With
regard to total CD4+ T cells, the highest numbers of such cells were present in the
eyes of IL-10-/- animals (Fig. 2D). Comparing the ratio of Foxp3+CD4+ T cells to
Foxp3-CD4+ T cells, the ratio was lower in IL-10-/- animals as compared to WT
(Fig. 2E). Of note, before infection, the number of Foxp3+ cells in the secondary
lymphoid tissues was comparable to WT in IL-10-/- mice (data not shown).
Cellular analyses were also performed in single cell suspensions of pooled
trigeminal ganglia from the 3 groups of animals. As with the corneas,
inflammatory cell numbers were elevated in the TG of IL-10-/- and nTreg depleted
compared to WT animals (Fig 2F). In addition, the frequency of both CD8+ and
CD4+ T cells were both elevated compared to WT with the highest frequencies
present in IL-10-/- animals (Fig. 2G).
Along with changes in inflammatory cell influx in the different groups of
mice, the numbers of IFN-γ and IL-17 producing CD4+ T cells were also measured
at day 17 in each group by intracellular cytokine staining. Once again the highest
frequencies of cytokine producing cells were present in the corneas of IL-10-/with Treg depleted showing less and WT the least amount (Fig. 3A-C). By
intracellular cytokine staining, we also looked for the cytokine producing CD4+ T
cells in the cervical lymph node and the spleen of these mice. As shown in Fig. 4,
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about three and eight fold increases in the numbers of CD4+ T cells producing
IFN-γ and TNF-α were found in the DLN and spleens in the absence of nTregs
and IL-10 respectively. This increase in proinflammatory mediators in the cornea
and secondary lymphoid tissues along with higher Treg numbers in IL-10-/animals may mean an inability of nTregs to suppress the disease pathology in the
proinflammatory milieu [21, 22] or that the pathogenic Th1 type CD4+ T cells
present at the site are resistant to nTregs mediated suppression [23, 24].
We

also

determined

the

magnitude

of

SSIEFARL

specific

(immunodominant epitope in C57BL/6 mice) CD8+ T cell responses and cytokine
production by CD8+ T cells in these animals. As shown in the Fig. 5A and B,
higher magnitude of immune responses were noted in the absence of either Tregs
(three fold) or IL-10 (two fold). Interestingly, in contrast to CD4+ T cells, the
increase in the total CD8+IFN-γ+ was greater in the absence of nTregs as compared
to IL-10 which could mean different pathways of immune response generation
could be influenced by IL-10 and nTregs.
Treg effects are still evident in IL-10-/- mice
One explanation for the greater susceptibility of IL-10-/- animals could
relate to the function of adaptive or natural Tregs. Thus the former cell type is
usually dependent on IL-10 so would not be expected to be present in IL-10-/animals. Studies in some cases have indicated that Foxp3+ natural Tregs may also
function at least in part by their production of IL-10 [25]. Another explanation
could be the dysfunction of nTregs in the presence of high concentration of
proinflammatory mediators, such as IL-6 and IL-12, at the site [22, 23]. In this
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regard, higher levels of IL-6 and IL-12 were found in the DLN and corneal lysates
of IL-10-/- animals as compared to WT (Fig. 6).
Experiments were performed in older IL-10-/- male mice, which are more
resistant to HSV induced lesions than the 6-8 weeks old female mice used in
previous experiments. To evaluate the role of nTregs in controlling SK lesion
development, Treg depleted IL-10-/- (DEP-IL-10-/-) were compared with non
depleted IL-10-/- animals As shown in Fig. 7A-D, depletion of CD25+ cells from
IL-10-/- animals resulted in increased SK lesions (7A and D) as well as angiogenic
responses (7B and D).At day 20 p.i., 55% eyes in depleted IL-10-/- animals had
SK scores of ≥ 3 compared with 25% in undepleted IL-10-/- mice (7C). At this
time point, the SK scores were 2.3 ± 0.3 (p ≤ 0.05) in Treg depleted IL-10-/- mice
as compared to 1 ± 0.2 in normal IL-10-/- animals. A similar pattern was also
evident in the development of neovascularization in the depleted IL-10-/- animals.
At day 20 p.i., Treg depleted IL-10-/- animals had neovascularization scores of 10.8
± 1.1 as compared to 7.4 ± 1 in control IL-10-/- animals. Additionally, there was
an earlier onset of SK lesions in the Treg depleted IL-10-/- animals as compared to
normal IL-10-/- animals. The incidence of SK at day 12 p.i. was 30 % and 58 %
in the IL-10-/- and DEP-IL-10-/- group respectively (Fig. 7C). Increased numbers
of IFN-γ+CD4+ T cells (Fig 7E) and other inflammatory cell influx were also noted
in the corneas and TG of such animals as compared to the controls (not shown).
Similarly, as shown in Fig. 7F, the virus specific CTL response, as assessed by the
frequency and the absolute number of virus specific CD8+IFN-γ+ T cells in the
secondary lymphoid tissues, was also significantly increased in the absence of
nTregs in the IL-10-/- animals. These results indicate that even in IL-10-/- animals,
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nTregs can exert their suppressive activity and that their function could be
independent of IL-10 in HSV induced corneal immunopathology.
To support the apparent IL-10 independent in vivo suppressive activity of
nTregs, we isolated CD4+CD25+ nTregs from uninfected WT and IL-10-/- animals
and those were cultured with CFSE labeled CD4+CD25- cells isolated from naïve
and 12 day post infected WT animals. Cells were stimulated with anti-CD3 and
accessory cells in vitro for 48 h. As is shown in Fig. 8B-D, both groups of nTregs
could equally suppress the proliferation (Fig. 8B) and cytokine production (Fig.
8D) from WT CD4+CD25- T cells.
What is the main cellular source of IL-10 in SK
Several reports have showed the production of IL-10 by Foxp3+ Tregs [25-27]. To
determine if in SK nTregs themselves produce IL-10 post infection, we measured
the IL-10 production using Foxp3-GFP mice at day 5, 11 and 18 p.i. As shown in
Fig. 8E and table 1, we could not detect substantial numbers of GFP+IL-10+ cells
in the lymphoid tissues although very few such cells were present in the infected
corneas at later time points post infection (Table. 1). Additionally, IL-10+IFNγ+CD4+ T cells were not evident in either cornea or lymphoid tissues (not shown).
These data suggest that non regulatory cells could be the major cellular source of
IL-10 p.i.
To further study the phenotype of the IL-10 producing cells in the infected
corneas and secondary lymphoid tissues, intracellular cytokine staining was
performed with cells taken from infected WT corneas, spleens and DLNs at day 5,
11, and 20 p.i. The cells were stained with surface markers such as c-kit, Gr-1,
CD11c, CD11b, B220, CD19, CD25, CD3, NK1.1, and CD4 along with
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intracellular IL-10. As shown in Table. 1, the majority of the IL-10 producing cells
in the spleen and DLNs also expressed B220, CD25 and F4/80 markers. More than
50% of the cells also expressed c-kit and Gr1 markers (data not shown).
Interestingly, as shown in the Table 1, in the infected corneas non regulatory cells
with the CD11b+Gr1+ phenotype along with a minor population of Foxp3-CD4+
and a few F4/80+ cells produced IL-10.
Influence of nTreg on IL-10 production
Since our results indicated that Treg could have IL-10 independent suppression in
SK, and that these cell types did not constitute a significant part of the IL-10
producing cell types, we determined whether the activity of nTregs could influence
the production of IL-10 p.i. In many reports, Tregs were shown to suppress
immune responses via IL-10 production [8, 28]. Interestingly, as measured by
intracellular cytokine staining and cytokine ELISA, an increase in the absolute
number and frequencies of IL-10 producing cells as well as IL-10 proteins was
noted in the lymphoid tissues in the absence of Tregs in the WT animals as
compared to undepleted WT animals (Fig. 9A and B). But the mean fluorescence
intensity (MFI) of IL-10+ cells remained comparable among Treg depleted and
undepleted WT animals and similar was the case of phenotype of IL-10 producing
cells (Data not shown). This could be due to the generalized suppressive activity of
Tregs on the IL-10 producing cell types such as macrophages or DCs or the
activated CD4+ T cells. In contrast as is evident in the Fig. 9C, the level of IL-10 in
the corneas of Treg depleted WT mice was lower as compared to undepleted WT
animals at day 4 and day 9p.i.
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Discussion
Many

chronic

immunoinflammatory

diseases

are

difficult

to

control

therapeutically. One such example is SK caused by HSV infection of the eye. It is
anticipated that control measures will improve once mechanisms involved in
lesion resolution are all identified and their respective role fully understood. With
regard to SK, few studies have been done, but reports have demonstrated that
upregulation of certain cytokines such as IL-10 and TGF-β help resolve lesions
[29, 30]. Recently, observations in a variety of inflammatory diseases indicate that
several types of regulatory cells control and resolve inflammatory lesions and
some of these appear to function by producing either or both IL-10 and TGF-β
[31]. With SK, natural regulatory T cells were shown previously to influence
lesions but the mechanisms by which this is achieved were not identified [5]. In
some systems, nTregs appear to function independently of any cytokine
production [32], whereas in others IL-10 production is a necessary event [25, 28].
In this report, we show that both nTreg and IL-10 participate in the control
of SK lesion severity, but these two mechanisms proceed largely independently of
each other. Our results show that the severity of SK lesions become enhanced if
animals are unable to produce IL-10, because of gene knock out, or have been
depleted of nTreg. Furthermore, depletion of nTreg in IL-10-/- mice led to even
higher levels of disease severity than in undepleted IL-10-/- mice. In addition,
nTreg purified from WT and IL-10-/- animals appeared to be equally suppressive
in vitro to the activity of non regulatory cells. Few if any Foxp3+CD4+ Treg in
both the ocular lesions or draining LN were IL-10 producers, In fact, the major
source of IL-10 appeared to be non T cells such as granulocytes and mononuclear
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inflammatory cells. Accordingly, these HSV induced immunoinflammatory
lesions can be modulated independently by both IL-10 and nTreg activity which
could mean that future novel therapies will need to manipulate both mechanisms to
achieve maximal effects.
The means by which inflammatory lesions are influenced by regulatory T
cells remain poorly understood especially in responses caused by pathogens [33].
In some virus induced immunoinflammatory lesions, some advocate a major role
for adaptive Tregs induced by antigen in the presence of IL-10 [9, 34]. These socalled Tr1 cells regulate responses by producing an abundance of IL-10 [9, 34].
Their role in SK remains unexplored. In other systems, such as Leishmania
infections, cells of the nTreg phenotype control lesions but these appear to act by
producing IL-10 [35, 36]. The same may also be true in other parasite mediated
lesions as well as in bacterial induced colitis [36, 37]. Our results showing that a
significant nTreg effect could be demonstrated in mice genetically unable to
produce IL-10 strongly argues against IL-10 being a dominant mechanism by
which nTreg act in vivo. Similarly such cells isolated from IL-10-/- mice acted
equally to those from WT animals in vitro indicating no role for IL-10 to mediate
their function as others have argued to be the case using different approaches [38].
It is conceivable that several functional subsets of the Foxp3+ regulatory
phenotype exist. Those thymic derived autoantigen specific cells, that are
primarily depleted by pc61 mAb in naïve mice, may function in a different way to
those converted in vivo from CD4+Foxp3- foreign antigen specific precursors. This
conversion process was shown recently to occur by several groups [39-41]
including ourselves [6]. We suspect that the nTregs preexisting at the time of
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infection are signaled in some way by the HSV infection and these control SK in a
manner that does not depend on IL-10 production. In contrast, the Foxp3+ Tregs
that act in more chronic infections may largely represent Foxp3+ converts and
these may function primarily by producing IL-10. Since we have recently
succeeded in generating Foxp3+ Treg converts from non regulatory precursors [6],
we are now in the position to compare these with normal nTregs for their ability to
modulate SK as well as their dependence on IL-10 production. Such studies are in
progress.
Although our results could not define the site at which IL-10 and nTregs
function to control SK lesions, we suspect they may be quite different. We
anticipate that IL-10 acts mainly at the ocular site to control lesions. Moreover, the
major source of this cytokine was shown to be non regulatory cells having the
CD11b+Gr1+ and F4/80+ phenotype. Some of these cells may be equivalent to the
CD11b+Gr1+ myeloid suppressor cells described in some tumor systems [42]. We
also demonstrated that the IL-10 appeared to act by inhibiting the production of
proinflammatory cytokines such as IFN-γ, IL-17 and TNF-α. Cells producing such
cytokines were more abundant in lesions of IL-10-/- than in WT animals. The
results of several other observations also support a similar anti-inflammatory effect
of IL-10 [43, 44].
Although our observations as well as former reports show the presence of
Tregs at the site of inflammation [5, 24, 45], we can not assess whether or not they
exert a suppression effect in the inflamed tissue. In fact whether Tregs function at
inflammatory site remains debatable. Thus, one report showed that Tregs taken
from an inflammatory site failed to suppress pathogenic T cells isolated from the
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lesions when tested in vitro [24], perhaps because their activity was inhibited by
one or more inflammatory cytokines as has been shown to occur in vitro [22, 23].
Interestingly, others have shown that Tregs do proliferate at such sites and that
they can suppress IFN-γ, although not IL-17 production, by CD4+CD25- T cells
isolated from the lesion site [45]. In our current study, WT mice depleted of nTreg
had higher levels of proinflammatory cytokines in the lesions as well as in the
lymphoid tissues. Conceivably, such cytokines could inhibit their function, but this
issue requires further evaluations using Tregs isolated from the inflamed cornea at
different time points p.i.
A body of evidence favors the idea that nTregs mainly act to regulate in
lymphoid tissues [46]. Our data favors this idea too. Accordingly, in nTreg
depleted WT animals the absolute numbers of IL-10 producing cells in the
draining LN and spleen were increased accounting at least in part for the inhibitory
effects that occurred. In addition, Treg depletion resulted in better HSV specific
immune response providing more of the effector cells responsible for mediating
SK.
One surprising result of our observations was that an effect of nTreg was
easy to demonstrate even when the cells were called upon to function in an
environment rich in cytokines assumed to impair their function. Thus we
demonstrated marked elevations of cytokines such as IL-6 and IL-12 in the LNs
and ocular tissues of infected IL-10-/- compared to similarly infected WT animals.
Despite this, an effect of nTreg depletion was readily apparent in the IL-10-/infected mice. These results may mean either that in the in vivo inflammatory
environment the inhibitory effects of some cytokines observed in vitro is not a
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major effect, or that the Tregs function at certain sites such as in LNs where
effector cells are being generated is not inhibited by inflammatory cytokines.
Some recent observations on EAE also support the concept that effector cell
functions in lymphoid sites may be inhibited by Foxp3+ Tregs whereas at the same
time effectors at lesion site may resist such regulation[24]. These issues are under
further investigation in the SK system.
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Figure 1. Increased SK lesions in the absence of IL-10 and nTregs
A. Percentage of CD4+CD25+ T cells in the spleens at day 4 of the animals
depleted of nTregs by α-CD25 antibody (pc61 mAb, 0.7mg) treatment.
Staining for CD25 was performed with FITC labeled anti-CD25 (clone7D4)
antibody. Left dot plot shows the spleen of an untreated control animal.
B. The bar diagram demonstrates the percentage severity of each group of mice
infected with 5 × 105 pfu HSV-1 RE at day 16 p.i. The IL-10-/- and Treg
depleted mice showed increased incidence (SK score ≥ 3) of disease as
compared to WT animals.
C. SK lesion scores of individual eyes at day 16 p.i of WT, DEP-WT (Treg
depleted WT), and IL-10-/-, mice infected with 5 × 105 pfu infection dose.
D. SK lesion scores in three groups of mice at different time points p.i. ∗, (P ≤
0.05), statistically significant differences as compared to WT control.
E. Angiogenesis lesion scores of individual eyes at day 16 p.i of WT, DEP-WT,
and IL-10-/-, mice infected with 5 × 105 pfu infection dose.
F. Angiogenesis sores at different time points p.i. in the three groups of mice. ∗,
(P ≤ 0.05), statistically significant differences as compared to WT control.
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Figure 2. Increased inflammation in the corneas of mice deficient in IL-10
and nTregs
A. Mice were infected with 5 × 105 pfu HSV-1 RE. Mice were terminated at
Day 17 p.i., and eyes were processed for cryo-section. Hematoxylin and eosin
staining was carried out on 6-μm sections. The figure shows the pictures of the
section taken at 10x magnification.
B. Single-cell suspensions of the infected corneas were prepared from six
corneas at day 17 p.i. for each group of mice. The cells were labeled for
Gr1+CD11b+ (PMNs) cells. The dot plots represent the Gr1+CD11b+ cells in
the WT, DEP-WT and IL-10-/- corneas. The number on the dot plots denotes
the percentage of inflammatory cells expressing both Gr1+ and CD11b+
markers.
C. The bars represent the total number of viable cells present per cornea of
different groups of mice.
D. The cells isolated from infected corneas at day 17 p.i were stained for CD4
marker and the bars represent the total number of CD4+ T cells present per
cornea of different groups of mice.
E. Intra-nuclear staining for CD4+Foxp3+ nTregs was performed with the cells
isolated from corneas. The bars represent the percentage of CD4+Foxp3+ cells
present in the total CD4+ T cells per cornea of different groups of mice.
F. Single-cell suspensions were prepared from four TGs at day 17 p.i. for
each group of mice. The cells were labeled for Gr1+CD11b+ cells. The dot
plots represent the Gr1+CD11b+ cells in the WT, DEP-WT and IL-10-/- corneas
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Figure. 2 cont.
The number on the dot plots denotes the percentage of inflammatory cells
expressing both Gr1+ and CD11b+ markers in TG.
G. The cells from TGs were labeled for CD4+ and CD8+ cells. The dot plots
represent the CD4+ and CD8+ cells in the WT, DEP-WT and IL-10-/- corneas.
The number on the dot plots denotes the percentage of inflammatory cells
expressing CD4+ and CD8+ markers.
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Figure 3. Increased number of CD4+IFN-γ+ T cells in the corneas of mice
deficient in IL-10 and nTregs
Single-cell suspensions of corneal cells were prepared from six corneas at day 17
p.i. Cells were stimulated with either anti-CD3 and anti-CD28 antibody or UVHSV. Intracellular IFN-γ staining along with CD4 surface staining was carried out
as described in materials and methods. The results in the figure represent the data
from one of two similar experiments.
A. Dot plots represent the frequencies of CD4+IFN-γ+ T cells when gated on the
lymphocytes.
B. The bar diagram demonstrates the total number of CD4+IFN-γ+ in the cornea
in different groups.
C. The bar diagram demonstrates the total number of CD4+IL-17+ in the cornea
in different groups.
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Figure 4. Increased number of IFN-γ+ and TNF-α+ CD4 T cells in the secondary
lymphoid tissues of IL-10-/- mice as compared to nTregs depleted and WT mice
Single-cell suspensions of the individual spleen and the cervical draining lymph
nodes (DLN) were prepared from four mice of each group at day 17 p.i. Cells were
stimulated with either anti-CD3 and anti-CD28 antibody or UV-HSV as described
in the materials and methods. Intracellular cytokine staining along with CD4
surface staining was carried out as described in materials and methods. In fig. A
and B, dot plots represents the frequencies of CD4+IFN-γ+ and CD4+TNF-α+ T
cells respectively in the lymphoid tissues of different groups of mice when gated
on the lymphocytes. Bar diagram demonstrates the total number of CD4+IFN-γ+
and CD4+TNF-α+ T cells per DLN or Spleen in different groups (N=4 per group).
*, (P ≤ 0.05), statistically significant differences as compared to WT animals.
Note: Similar pattern was also noticed in the number of CD4+IL-17+ T cells.
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Figure 5. Increased number of SSIEFARL peptide specific CD8+IFN-γ+ T cells
in the secondary lymphoid tissues of mice deficient in nTregs as compared to
IL-10-/- and WT
Single-cell suspensions of the spleen and the cervical lymph nodes were prepared
from four mice of each group at day 17 p.i. SSIEFARL specific CD8+ IFN-γ+
staining was carried out as described in materials and methods.
A. The dot plots in the figure represent the frequencies of CD8+IFN-γ+ cells
(CD8+ on the x-axis and IFN-γ+ on the y-axis). The numbers on the upper
right quadrants represent the percentage of CD8+IFN-γ+ T cells in the gated
population of lymphocytes in the spleens. The plots are representative of
four animals analyzed per each group (N=4).
B. The bar diagram demonstrates the total number of double positive cells per
DLN or Spleen in different groups. ∗, (P ≤ 0.05), and **, (P ≤ 0.01)
statistically significant differences as compared to WT animals
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Figure 6. Increased expression of inflammatory mediators in the corneas and
lymphoid tissues of mice deficient in IL-10 and nTregs
At the indicated time points, six corneas/group and cervical lymph nodes from
individual animals were processed to measure the IL-6, and IL-12 levels. Level of
cytokines were measured in the supernatants of tissue lysates of WT, DEP-WT
and IL-10-/- animals infected with 5 × 105 pfu HSV-1 RE using sandwich ELISA
as outlined in materials and methods. Bar diagrams in Fig. A, and B represent the
levels of IL-12 and IL-6 in the corneal and DLN lysates of the three groups of
animals.*, (P ≤ 0.05), statistically significant difference as compared to WT
animals.
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Figure 7. Increased SK severity in the absence of nTregs in the IL-10-/- animals
A. Mean SK lesion scores at different time point p.i. of Treg depleted IL-10-/(DEP-IL10-/-) and undepleted IL-10-/- animals. ∗, (P ≤ 0.05), statistically significant
differences as compared to undepleted IL-10-/- mice.
B. Mean angiogenesis scores at different time point p.i. of Treg depleted IL-10-/(DEP-IL-10-/-) and undepleted IL-10-/- animals. ∗, (P ≤ 0.05), statistically
significant differences as compared to undepleted IL-10-/- mice.
C. Bar diagram demonstrate the percentage severity (SK score ≥ 3) of both the
groups of mice at day 14 and day 20 p.i.
D. Eye pictures showing the lesion severity at day 18 p.i. in IL-10-/- and DEP-IL10-/- animals.
E. Single-cell suspensions of corneal cells were prepared from six corneas at day
20 p.i. Cells were stimulated with either anti-CD3 and anti-CD28 antibody or
UV-HSV. Intracellular IFN-γ staining along with CD4 surface staining was
carried out as described in materials and methods. Bar diagram demonstrate
the total number of CD4+IFNγ+ T cells/ cornea at day 17 p.i.
F. Single-cell suspensions of the spleen and the cervical lymph nodes were
prepared from four mice of each group at day 20 p.i. SSIEFARL specific
CD8+IFN-γ+ staining was carried out as described in materials and methods.
The bar diagram demonstrates the total number of double positive cells per
DLN or spleen in different groups. ∗, (P ≤ 0.05), statistically significant
differences as compared to undepleted IL-10-/- animals.
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Figure 8. nTregs from both IL-10-/- and WT animals can equally suppress the
proliferation and cytokine production from conventional T cell isolated from WT
animals
CD4+CD25+ and CD4+CD25- cells were isolated as described in materials and
methods and were cultured in the presence of irradiated splenocytes and anti-CD3.
Culture supernatants were collected at 48 hr and the level of cytokines was
analyzed by sandwich ELISA. For measuring proliferation of non Tregs,
CD4+CD25- from Thy1.1 mice were labeled with CFSE and the extent of
suppression activity was assessed from the intensity of CFSE staining.
A. Dot plots show the purity of isolated CD4+CD25+ T cells from WT and IL-10-/mice.
B. Histograms demonstrate the suppression of proliferation of conventional T
cells by nTregs isolated from IL-10-/- (lower panel) and WT (upper panel)
animals. Proliferation of CD4+CD24- T cells are shown at 1:1, 1:4 and 1:8
dilutions of CD4+ CD25+ nTregs. Grey dotted lines denote the division of
CD4+CD25- T cells in the absence of nTregs and the solid lines show the
suppression in the presence of nTregs.
C. Bar diagrams show the levels of IFN-γ in the 48 hr culture supernatant in the
presence and absence of nTregs. As shown in the figure, both the nTregs could
equally suppress the cytokine production.
D. Bar diagrams show the levels of IL-2 in the 48 hr culture supernatant in the
presence or absence of nTregs.
E. GFP-Foxp3 mice were infected with HSV-RE and intracellular staining for IL10 was performed as outlined in the materials and methods. As shown in the
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Figure 8 cont.
dot plots, no IL-10+ and GFP+ cells were detected in the lymphoid tissues after
infection.
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Figure 9. A. Tregs do not produce IL-10 but can influence the IL-10 production
from other cell types in the lymphoid tissues
To ascertain the effect of Tregs on IL-10 production, total numbers of IL-10+ cells
were measured in the Treg depleted and undepleted animals. A. The bar diagram
demonstrates an increase in the number of IL-10+ cells in the lymphoid tissues of
Treg depleted animals. B. The bar diagram demonstrates an increase in the IL-10
and IFN-γ protein levels in the Treg depleted animals as compared to undepleted
WT animals at day 6 p.i. C. The bar diagram demonstrates the level IL-10 in the
corneal lysates of Treg depleted animals as compared to undepleted WT animals at
day 4 and 9 p.i. ∗, (P ≤ 0.05), statistically significant differences as compared to
undepleted WT animals.
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Table 1.
Phenotype of IL-10 producing cells in various tissues

Days
p.i.
5

+

CD4

+

Foxp3
+

Gr1 CD11b

+

Spleen

DLN

30

<5

5±2

0

UD

UD

50

-

-

10

6±2.6

<5

+

-

62±4.2

65±11

+

-

40±4

45±8

5-10

7±2.5

5±3.2

2

UD

UD

B220

CD25

+

CD4

+

Foxp3
+

Gr1 CD11b

+

80

-

-

+

5

14±3.2

7.6±3

+

B220

-

77±4.3

89±2

CD25+

-

65±3

73±4.3

CD4+

5-10

UD

UD

Foxp3+

2-5

<1

<1

Gr1+CD11b+

70-80

-

-

F4/80+

<5

20±5

25±2.5

B220+

-

83±3

84±4

CD25+

-

55±5

60.5±6

F4/80

20

Cornea

+

F4/80

11

% of Total IL-10+ cells

Surface markers

* The number of Foxp3+IL-10+ cell number is determined by using
GFP+IL10+ cell

number. After day 20 p.i.an increase in the number of these

double positive cells was noticed in the infected corneas but not in the
lymphoid tissues.
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